MEADOWBROOK REHABILITATION GROUP INC
8-K, 1998-04-22
SKILLED NURSING CARE FACILITIES
Previous: TANKNOLOGY NDE INTERNATIONAL INC, DEF 14A, 1998-04-22
Next: CB COMMERCIAL REAL ESTATE SERVICES GROUP INC, 8-K, 1998-04-22






                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                            ------------------------


                                    FORM 8-K
                                 CURRENT REPORT


                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934


                Date of Report (Date of earliest event reported):
                                  April 7, 1998



                     MEADOWBROOK REHABILITATION GROUP, INC.
             (Exact name of registrant as specified in its charter)


    Delaware                       0-19726                   94-3022377
(State or other                (Commission File          (I.R.S.  Employer
jurisdiction of                 Number)                   Identification Number)
incorporation)


              2000  Powell Street, Suite 1203, Emeryville,  CA 94608 
                    (Address of principal executive offices)


               Registrant's telephone number, including area code:
                                 (510) 420-0900








<PAGE>


Item 5.           Other Events

         On April 7, 1998, the Registrant  announced that it had entered into an
Agreement  and Plan of Merger  (the  "Agreement")  by and among the  Registrant,
Interset,  Inc., a wholly owned  subsidiary of the Registrant  ("Interset")  and
Cambio Networks,  Inc.  ("Cambio").  The Agreement  provides that the Registrant
will acquire each issued and outstanding  share of common and preferred stock of
Cambio through the merger of Interset with and into Cambio,  which will become a
wholly owned  subsidiary of the  Registrant.  Under the terms of the  Agreement,
Cambio's current shareholders will receive the Registrant's Class A Common Stock
representing  32.5% of the  outstanding  Class A and Class B Common Stock at the
time of the closing. The closing of the merger is subject to several conditions,
including the approval of the stockholders of each of the Registrant and Cambio.
Based in Bellevue, Washington, Cambio is a network management inventory software
company providing services to financial,  telephony,  medical and Y2K markets in
both the US and Common Market.

         A copy of the press release  announcing  the execution of the Agreement
is attached as Exhibit 99.1 and is incorporated herein by reference.

         On April 3, 1998, the  Registrant and Cambio  executed a Secured Bridge
Financial  Note (the "Note") to which the  Registrant  agreed to provide  Cambio
with a loan of up to five hundred  thousand dollars  ($500,000),  to finance its
ongoing  operations.  The note  bears  interest  at 8% per  annum and is due the
earliest  of (1) July 31,  1998;  (2) the closing of the  acquisition  discussed
above; or (3) the occurrence of certain events as defined in the Note.

Item  7.          Financial Statements and Exhibits

         (c)      Exhibits:

                  Exhibit 2.1       Agreement  and  Plan of  Merger,  dated
                                    April  7,  1998,   between  the  Registrant,
                                    Cambio's majority shareholders and Cambio.

                  Exhibit 2.2       Secured  Bridge  Financial  Note  dated
                                    April 3, 1998  between  the  Registrant  and
                                    Cambio.

                  Exhibit 99.1      Press  release  dated  April  7,  1998
                                    announcing the execution of the Agreement.

                                   SIGNATURES

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                          MEADOWBROOK REHABILITATION GROUP, INC.


                                          By: /s/ Harvey Wm. Glasser, M.D.
                                          Harvey Wm. Glasser, M.D.
                                          President and Chief Executive Officer
Dated:   April 22, 1998


<PAGE>


                       SECURITIES AND EXCHANGE COMMISSION

                                    EXHIBITS
                                       TO
                                    FORM 8-K

                               DATED APRIL 7, 1998




                                  EXHIBIT 2.1


<PAGE>




                                                                  EXECUTION COPY







                          AGREEMENT AND PLAN OF MERGER



                                      Among

                     MEADOWBROOK REHABILITATION GROUP, INC.,

                                 INTERSET, INC.,

                             CAMBIO NETWORKS, INC.,

                                       and

                        THE SECURITYHOLDERS NAMED HEREIN







                                  April 7, 1998



<PAGE>



                                TABLE OF CONTENTS

                                                                            Page

ARTICLE I             THE MERGER.............................................  1
   1.1   The Merger..........................................................  1
   1.2   Closing.............................................................  1
   1.3   Effective Time......................................................  2
   1.4   Corporate Organization..............................................  2

ARTICLE II            EFFECT OF THE MERGER ON THE CAPITAL STOCK OF THE
                      CONSTITUENT CORPORATIONS...............................  2
   2.1   Conversion of the Company Shares....................................  2
   2.2   Conversion of Stock Options.........................................  3
   2.3   Surrender and Payment...............................................  3
   2.4   Dissenting Shares...................................................  4
   2.5   Adjustments.........................................................  5
   2.6   Fractional Shares...................................................  5

ARTICLE III           THE SURVIVING CORPORATION..............................  5
   3.1   Articles of Incorporation...........................................  5
   3.2   Bylaws..............................................................  5
   3.3   Directors and Officers..............................................  5

ARTICLE IV            REPRESENTATIONS AND WARRANTIES OF THE COMPANY..........  5
   4.1   Organization and Qualification......................................  6
   4.2   Capital Structure...................................................  6
   4.3   Subsidiaries; Equity Investments....................................  7
   4.4   Authority...........................................................  8
   4.5   No Conflict with Other Instruments..................................  8
   4.6   Governmental Consents...............................................  8
   4.7   Financial Statements................................................  9
   4.8   Absence of Changes..................................................  9
   4.9   Properties.......................................................... 11
   4.10  Environmental Matters............................................... 11
   4.11  Taxes............................................................... 12
   4.12  Employees........................................................... 13
   4.13  Compliance with Law................................................. 14
   4.14  Litigation.......................................................... 14
   4.15  Contracts........................................................... 14
   4.16  No Default.......................................................... 15
   4.17  Major Customers..................................................... 15
   4.18  Proprietary Rights.................................................. 15
   4.19  Insurance........................................................... 17
   4.20  Brokers or Finders.................................................. 17
   4.21  Related Parties..................................................... 17
   4.22  Certain Advances.................................................... 17
   4.23  No Misleading Statements............................................ 17


                                       -i-



<PAGE>


                                                                            Page


   4.24  Company Proxy Statement............................................. 17

ARTICLE V             REPRESENTATIONS AND WARRANTIES OF MEADOWBROOK
                      AND INTERSET........................................... 18
   5.1   Organization........................................................ 18
   5.2   Capital Structure................................................... 18
   5.3   Authority........................................................... 19
   5.4   No Conflict with Other Instruments.................................. 19
   5.5   Governmental Consents............................................... 20
   5.6   SEC Documents....................................................... 20
   5.7   Shares of Meadowbrook Common........................................ 20
   5.8   No Material Adverse Change.......................................... 21
   5.9   Nasdaq National Market.............................................. 21
   5.10  Brokers or Finders.................................................. 21
   5.11  Disclosure.......................................................... 21

ARTICLE VI            CONDUCT PRIOR TO THE EFFECTIVE TIME.................... 21
   6.1   Conduct of Business of the Company.................................. 21
   6.2   No Solicitation..................................................... 23
   6.3   Conduct of Business of Meadowbrook.................................. 24

ARTICLE VII           ADDITIONAL AGREEMENTS.................................. 25
   7.1   Approval of the Company Stockholders................................ 25
   7.2   Preparation of Company Proxy Statement.............................. 25
   7.3   Access to Information; Interim Financial Information................ 25
   7.4   Confidentiality..................................................... 26
   7.5   Expenses............................................................ 26
   7.6   Public Disclosure................................................... 26
   7.7   Reasonable Efforts.................................................. 27
   7.8   Conduct; Notification of Certain Matters............................ 27
   7.9   Tax-Free Reorganization............................................. 27
   7.10  Blue Sky Laws....................................................... 27
   7.11  Compliance with Exchange Act........................................ 27
   7.12  Meadowbrook Funding................................................. 28
   7.13  Meadowbrook Voting Agreement........................................ 28
   7.14  Registration Rights Agreement....................................... 28
   7.15  Additional Documents and Further Assurances......................... 28
   7.16  Indemnification..................................................... 28
   7.17  Waiver of Rights of First Refusal................................... 28

ARTICLE VIII          CONDITIONS TO THE MERGER............................... 28
   8.1   Conditions to Obligations of Each Party to Effect the Merger........ 28
   8.2   Additional Conditions to Obligations of the Company................. 29
   8.3   Additional Conditions to the Obligations of Meadowbrook and Interset 30



                                      -ii-




<PAGE>

                                                                            Page


ARTICLE IX            INDEMNIFICATION........................................ 31
   9.1   Survival of Representations and Warranties.......................... 31
   9.2   Indemnification..................................................... 32
   9.3   Exclusivity of Remedy............................................... 34

ARTICLE X      TERMINATION, AMENDMENT, WAIVER, CLOSING....................... 35
   10.1  Termination......................................................... 35
   10.2  Effect of Termination............................................... 36
   10.3  Termination Fee..................................................... 36
   10.4  Amendment or Supplement............................................. 36
   10.5  Extension of Time, Waiver........................................... 36

ARTICLE XI            GENERAL................................................ 37
   11.1  Notices............................................................. 37
   11.2  Headings............................................................ 38
   11.3  Counterparts........................................................ 38
   11.4  Entire Agreement; Assignment........................................ 38
   11.5  Severability........................................................ 39
   11.6  Other Remedies...................................................... 39
   11.7  Governing Law....................................................... 39
   11.8  Absence of Third-Party Beneficiary Rights........................... 39

EXHIBITS AND SCHEDULES

EXHIBITS
   Exhibit A          Form of Stockholders Voting Agreement
   Exhibit B          Form of Meadowbrook Voting Agreement
   Exhibit C          Form of Secured Bridge Financing Note
   Exhibit D          Form of Registration Rights Agreement

SCHEDULES
   Schedule 3.3       Officers of Surviving Corporation
   Schedule 4         Disclosure Schedule
   Schedule 4.2       Beneficial Owners of Company Stock and Holders of Company
                      Options
   Schedule 4.7       1998 Operating Budget





                                      -iii-



<PAGE>



                          AGREEMENT AND PLAN OF MERGER


        THIS AGREEMENT AND PLAN OF MERGER (this "Agreement"),  dated as of April
3,  1998,  by and  among  MEADOWBROOK  REHABILITATION  GROUP,  INC.  a  Delaware
corporation ("Meadowbrook"), INTERSET, INC., a Delaware corporation and a wholly
owned  subsidiary  of  Meadowbrook   ("Interset"),   CAMBIO  NETWORKS,  INC.,  a
California corporation (the "Company"),  and certain stockholders of the Company
named on the signature pages hereto (the "Securityholders").

                              W I T N E S S E T H:

        WHEREAS,  the  Boards of  Directors  of  Meadowbrook,  Interset  and the
Company  deem  it  advisable  and in the  best  interests  of  their  respective
stockholders  to effect the merger  hereafter  provided  for, in which  Interset
would  merge with and into the Company  and the  Company  would  become a wholly
owned subsidiary of Meadowbrook (the "Merger");

        WHEREAS,  concurrently with the execution and delivery of this Agreement
and as a condition and inducement to Meadowbrook's and Interset's willingness to
enter into this  Agreement,  each of the  Securityholders  are  entering  into a
Stockholders  Voting  Agreement  with  Meadowbrook  in  substantially  the  form
attached hereto as Exhibit A (the "Stockholders  Voting Agreement") which, among
other things,  requires  them to vote all the shares of Company  Stock  (defined
below) owned by them in accordance with the Stockholders Voting Agreement; and

        WHEREAS,   it  is  intended  that  the  Merger  qualify  as  a  tax-free
reorganization within the meaning of Section 368(a) of the Internal Revenue Code
of 1986, as amended (the "Code"):

        NOW,  THEREFORE,  in  consideration  of the  premises  and of the mutual
agreements, provisions and covenants herein contained, Meadowbrook, Interset and
the Company hereby agree as follows:


                                    ARTICLE I

                                   THE MERGER

        1.1 The Merger.  At the Effective Time (as defined in Section 1.3), upon
the terms and subject to the  conditions of this  Agreement,  Interset  shall be
merged  with and into the  Company in  accordance  with the  California  General
Corporation  Law (the  "CGCL") and the  Delaware  General  Corporation  Law (the
"DGCL"),  whereupon  the  separate  existence of Interset  shall cease,  and the
Company shall be the surviving corporation (the "Surviving Corporation").

        1.2  Closing.  The  closing  of the  transactions  contemplated  by this
Agreement (the "Closing") shall take place at the offices of Pillsbury Madison &
Sutro  LLP,  235  Montgomery  Street,  San  Francisco,  California  as  soon  as
practicable  following  satisfaction  or waiver of all of the  conditions to the
obligations of the parties to consummate the transactions contemplated hereby in
accordance  with this  Agreement  or at such  other  time,  place and date as is
mutually agreed to by


                                       -1-



<PAGE>



the  parties  hereto.  The date and time of the  Closing is  referred to in this
Agreement as the "Closing Date."

        1.3 Effective Time. As soon as practicable after satisfaction or, to the
extent permitted hereunder,  waiver of all conditions to the Merger, the Company
and Interset  shall file  certificates  of merger with the Secretary of State of
California  and the Secretary of State of Delaware and make all other filings or
recordings  required by the CGCL and the DGCL in connection with the Merger. The
Merger shall become  effective at such time as the certificate of merger is duly
filed with the  Secretary of State of the State of  California  (the  "Effective
Time").

        1.4  Corporate  Organization.  At and  after  the  Effective  Time,  the
Surviving  Corporation  shall  possess  all the rights,  privileges,  powers and
franchises and be subject to all of the restrictions, disabilities and duties of
the Company and Interset, all as provided under the CGCL and the DGCL.


                                   ARTICLE II

                           EFFECT OF THE MERGER ON THE
                  CAPITAL STOCK OF THE CONSTITUENT CORPORATIONS

        2.1 Conversion of the Company  Shares.  At the Effective Time, by virtue
of the Merger and without any action on the part of any holder of  securities of
Interset or the Company, the following shall occur:

        (a) Each share of common stock of Interset outstanding immediately prior
to the  Effective  Time  shall be  converted  into and become one fully paid and
nonassessable share of common stock, of the Surviving  Corporation with the same
rights, powers and privileges as the shares so converted,  and such shares shall
constitute  the only  outstanding  shares  of  capital  stock  of the  Surviving
Corporation.  Each stock certificate of Interset evidencing  ownership of shares
of common stock of Interset shall  continue to evidence  ownership of the shares
of capital stock of the Surviving Corporation.

        (b) Each share of Company  Stock (as defined in Section  4.2(a)) held by
the Company as  treasury  stock or owned by  Meadowbrook  or any  subsidiary  of
Meadowbrook  immediately  prior to the Effective Time shall be canceled,  and no
payment shall be made with respect thereto.

        (c) The shares of Company Stock issued and outstanding immediately prior
to the  Effective  Time  (except as otherwise  provided in Section  2.1(b) or as
provided  in Section  2.6 with  respect  to shares of Company  Stock as to which
appraisal  rights have been properly  exercised under the CGCL) shall, by virtue
of the Merger and  without  any  action on the part of the  holder  thereof,  be
converted  into the right to receive  shares of Class A Common  Stock,  $.01 par
value, of Meadowbrook (the  "Meadowbrook  Common")  representing  thirty-two and
one-half  percent  (32.5%) of the  outstanding  Meadowbrook  Class A and Class B
Common Stock at the Effective Time, assuming the exercise of all Company Options
outstanding as of the date of this Agreement and no exercise of any  Meadowbrook
Options  (as defined  below).  The number of shares of  Meadowbrook  Common into
which each share of Company Stock will be converted (the "Exchange  Ratio") will
be calculated immediately prior to the Effective Time.



                                       -2-



<PAGE>



        2.2    Conversion of Stock Options.

        (a) At the  Effective  Time,  by virtue of the  Merger and  without  any
action on the part of the holders thereof, each unexpired and unexercised option
to  purchase  shares of  Company  Stock  (individually  a "Company  Option"  and
collectively  the "Company  Options")  granted  under the  Company's  1994 Stock
Option Plan, (the "Company Plan") outstanding immediately prior to the Effective
Time  shall be  converted  into an  option  to  purchase  Meadowbrook  Common (a
"Converted  Company  Option") (the  aggregate  number of shares of Company Stock
issuable upon the exercise of all outstanding  Company Options immediately prior
to the Effective Time is referred to herein as the "Outstanding Option Amount").
Each Company  Option so converted by  Meadowbrook  will continue to have, and be
subject  to,  substantially  the same  terms  and  conditions  set  forth in the
documents governing such Company Option immediately prior to the Effective Time,
except  that (i) such  Converted  Company  Option will be  exercisable  for that
number of whole shares of  Meadowbrook  Common as is equal to the product of the
number of shares of Company Stock that were purchasable under the Company Option
immediately  prior to the  Effective  Time,  multiplied  by the Exchange  Ratio,
rounded  down to the nearest  whole number of shares of  Meadowbrook  Common and
(ii) the per share  exercise  price for the  Meadowbrook  Common  issuable  upon
exercise of such Converted Company Option will be equal to the quotient obtained
by dividing the exercise price per share of the shares of Company Stock at which
such Company Option was exercisable  immediately  prior to the Effective Time by
the Exchange  Ratio,  rounded up to the nearest whole cent.  The parties  intend
that the conversion of the Company Options  hereunder will meet the requirements
of  Section  424(a) of the Code and this  Section  2.2(a)  shall be  interpreted
consistent with such intention. Consistent with the terms of the Company Options
and the documents  governing such Company Option,  the Merger will not terminate
or accelerate any Converted Company Option or any right of exercise,  vesting or
repurchase  relating  thereto with respect to Meadowbrook  Common  acquired upon
exercise of such Converted Company Option.

        (b) As soon as practicable  after the Effective Time,  Meadowbrook shall
issue to each holder of a Converted  Company  Option a document  evidencing  the
conversion of such holder's Company Option by Meadowbrook.

        2.3    Surrender and Payment.

        (a) Prior to the Effective  Time, the Company shall provide  Meadowbrook
with a list of the names and addresses of each of the Company's stockholders for
the  purpose  of  assisting   Meadowbrook  in  exchanging   certificates  which,
immediately  prior to the  Effective  Time  represented  issued and  outstanding
shares of Company Common, for the consideration set forth in Section 2.1(c) (the
"Merger  Consideration").  Promptly after the Effective Time,  Meadowbrook shall
send,  or shall cause to be sent,  to each holder of record of shares of Company
Stock at the  Effective  Time a letter of  transmittal  for use in such exchange
(which shall specify that the delivery  shall be effected,  and risk of loss and
title shall pass,  only upon proper  delivery of the  certificates  representing
shares of Company Stock to the Meadowbrook).

        (b) Holders of shares of Company Stock that have been  converted  into a
right to receive the Merger  Consideration,  upon  surrender to Meadowbrook of a
certificate or certificates  representing such shares of Company Stock, together
with a properly  completed letter of transmittal  covering such shares,  will be
entitled to receive the Merger Consideration  payable in respect of such Company
Stock. Until so surrendered, each certificate representing shares of the Company
Stock


                                       -3-



<PAGE>



shall,  after the Effective  Time,  represent for all purposes only the right to
receive such Merger Consideration.

        (c) The Meadowbrook Common comprising the Merger  Consideration shall be
duly authorized,  validly issued, fully paid and non-assessable,  free and clear
of any liens,  pledges or  encumbrances  of any kind except any  restrictions on
subsequent  sale  by  the  Securityholders  imposed  by  any  federal  or  state
securities laws or regulations; provided however that each Securityholder hereby
agrees that it shall not effect any sale of Meadowbrook  Common issued  pursuant
to this  Agreement  for a period of twelve (12) months  following  the Effective
Time.

        (d) If any portion of the Merger Consideration is to be paid to a person
other than the registered  holder of shares of Company Stock  represented by the
certificate  or  certificates  surrendered in exchange  therefor,  it shall be a
condition to such payment that the  certificate or  certificates  so surrendered
shall be properly  endorsed or  otherwise  be in proper  form for  transfer  and
accompanied  by all  documents  required to evidence and effect the transfer and
that the person requesting such payment shall pay to Meadowbrook any transfer or
other  taxes  required  as a result of such  payment to a person  other than the
registered holder of shares of Company Stock or establish to the satisfaction of
Meadowbrook that such tax has been paid or is not payable.

        (e) After the Effective Time, there shall be no further  registration of
transfers  of  Company  Stock.  If,  after  the  Effective  Time,   certificates
representing shares of Company Stock are presented to the Surviving Corporation,
they shall be canceled and exchanged for the consideration  provided for, and in
accordance with the procedures set forth, in this Article II.

        (f) Any  amounts  remaining  unclaimed  by  holders of shares of Company
Stock three (3) years after the  Effective  Time (or such  earlier date prior to
such time as such amounts would  otherwise  escheat to or become property of any
governmental  entity) shall,  to the extent  permitted by applicable law, become
the  property  of  Meadowbrook  free and clear of any claims or  interest of any
person previously entitled thereto.

        (g) No  dividends,  interest  or other  distributions  with  respect  to
Meadowbrook Common  constituting part of the Merger  Consideration shall be paid
to the holder of any unsurrendered  certificates  representing shares of Company
Stock until such  certificates  are surrendered as provided in this Section 2.3.
Upon such surrender,  there shall be paid,  without  interest,  to the person in
whose name the  certificates  representing  Meadowbrook  Common  into which such
shares of Company Stock were converted are registered,  all dividends,  interest
and other distributions  payable in respect of such shares of Company Stock on a
date subsequent to, and in respect of a record date after, the Effective Time.

        2.4 Dissenting Shares. Notwithstanding Section , shares of Company Stock
outstanding immediately prior to the Effective Time and held by a holder who has
not voted or consented  to the Merger in writing and who has demanded  appraisal
for such Company Shares in accordance  with the CGCL shall not be converted into
a right to receive the Merger Consideration,  unless and until such holder fails
to perfect or withdraws or otherwise loses such holder's right to appraisal.  If
after the Effective Time such holder fails to perfect or withdraws or loses such
holder's right to appraisal, such shares of Company Stock shall be treated as if
they had been  converted  as of the  Effective  Time into a right to receive the
Merger  Consideration.  The Company shall give Meadowbrook  prompt notice of any
demands received by the Company for appraisal of shares of Company Stock,


                                       -4-



<PAGE>



and  Meadowbrook  shall have the right to  participate in all  negotiations  and
proceedings with respect to such demands. The Company shall not, except with the
prior  written  consent of  Meadowbrook,  make any payment  with  respect to, or
settle or offer to settle, any such demands.

        2.5  Adjustments.  If at any time during the period  between the date of
this Agreement and the Effective Time, any change in the  outstanding  shares of
capital  stock  of  Meadowbrook   shall  occur,   including  by  reason  of  any
reclassification,  recapitalization,  stock  split or  combination,  exchange or
readjustment of shares,  or any stock dividend thereon with a record date during
such period, the number of shares of Meadowbrook Common constituting all or part
of the Merger Consideration shall be appropriately adjusted.

        2.6 Fractional  Shares. No fractional shares of Meadowbrook Common shall
be issued in the Merger.  All  fractional  shares of  Meadowbrook  Common that a
holder of shares of Company  Stock would  otherwise  be entitled to receive as a
result of the Merger shall be aggregated and if a fractional  share results from
such aggregation,  such holder shall be entitled to receive, in lieu thereof, an
amount in cash determined by multiplying  such  fractional  share by the closing
price per share of Meadowbrook  Common on the Nasdaq Stock Market on the trading
day immediately prior to the Effective Time.


                                   ARTICLE III

                            THE SURVIVING CORPORATION

        3.1  Articles of  Incorporation.  The articles of  incorporation  of the
Company in effect at the Effective  Time shall be the articles of  incorporation
of the Surviving Corporation until amended in accordance with applicable law.

        3.2 Bylaws.  The Bylaws of the Company in effect at the  Effective  Time
shall be the Bylaws of the  Surviving  Corporation  until  amended in accordance
with applicable law.

        3.3  Directors  and Officers.  From and after the  Effective  Time,  the
directors  and  officers  of  Interset  shall  be the  directors  and  officers,
respectively,  of the  Surviving  Corporation  each as set forth on Schedule 3.3
attached hereto. In addition,  at the Effective Time, pursuant to the terms of a
Voting  Agreement  substantially  in the form of Exhibit B attached  hereto (the
"Meadowbrook  Voting  Agreement"),  the  size  of  the  Board  of  Directors  of
Meadowbrook  shall be  increased  to six (6)  members  and three  (3)  directors
nominated by the Company (and  reasonably  acceptable to  Meadowbrook)  shall be
appointed to the Board of Directors of Meadowbrook.


                                   ARTICLE IV

                  REPRESENTATIONS AND WARRANTIES OF THE COMPANY

        Except as otherwise  specifically  set forth on the disclosure  schedule
delivered by the Company to Meadowbrook prior to the execution of this Agreement
and signed by the  President of the Company  (the  "Disclosure  Schedule"),  the
Company represents and warrants to both Meadowbrook and Interset as follows:


                                       -5-



<PAGE>




        4.1  Organization  and  Qualification.  Each  of  the  Company  and  its
Subsidiary  is a  corporation  duly  organized,  validly  existing  and in  good
standing under the laws of its jurisdiction of incorporation or organization and
has all requisite  power and authority to own,  lease and operate its respective
properties and to carry on its business as now being conducted.  As used in this
Agreement,  "Subsidiary"  means a  corporation,  partnership  or other entity in
which the Company owns directly or indirectly fifty percent (50%) or more of the
voting  stock,  profits,  equity or  beneficial  interest,  is a partner  of, or
otherwise  controls  the  management  of.  Cambio  Networks,   Europe,  Inc.,  a
California  corporation  and, a wholly owned  Subsidiary of the Company,  is the
only Subsidiary of the Company.

        Each of the Company and its  Subsidiary is qualified to do business as a
foreign  corporation  and is in good  standing  under the laws of each  state or
other   jurisdiction  in  which  the  nature  of  its  business   requires  such
qualification,  which  states or  jurisdictions  are  listed  on the  Disclosure
Schedule, except where the failure to be so qualified or in good standing which,
taken  together  with  all  other  such  failures,  has not had,  or  would  not
reasonably be expected to have, a Material Adverse Effect on the Company and its
Subsidiary, taken as a whole. As used in this Agreement, Material Adverse Effect
on or with respect to an entity (or group of  entities,  taken as a whole) means
such event,  change or effect is materially  adverse to the business,  condition
(financial  or  otherwise),  properties,  assets,  liabilities,  or  results  of
operations  of such  entity  (or,  if with  respect  thereto,  of such  group of
entities  taken as a whole)  other than as a result of (i)  general  economic or
industry  conditions,  or (ii) the performance by the Company of its obligations
under this Agreement.

        The  Company  has  delivered  or made  available  to  Meadowbrook  true,
complete  and  correct  copies,  with  respect  to each of the  Company  and its
Subsidiary, of its (i) Amended and Restated Articles of Incorporation and Bylaws
(or other applicable  charter  documents),  as amended to the date hereof,  (ii)
minutes of all of directors'  and  stockholders'  meetings (or other  applicable
meetings),  complete and accurate as of the date hereof, (iii) stock certificate
books and all other  records that  collectively  correctly  set forth the record
ownership  of all  outstanding  shares  of its  capital  stock or  other  equity
interests and all rights to purchase  capital  stock or other equity  interests,
and (iv) form of stock  certificates,  option  agreements and rights to purchase
shares of its capital stock or other equity interests. Such Amended and Restated
Articles of Incorporation and Bylaws and other applicable  charter documents are
in full force and effect.

        4.2    Capital Structure.

        (a) The authorized  capital stock of the Company consists of ten million
(10,000,000)  shares of common stock,  no par value  ("Company  Common") and ten
million   (10,000,000)  shares  of  preferred  stock,  no  par  value  ("Company
Preferred"). As of the date of this Agreement, there were issued and outstanding
four hundred twenty-three thousand eighty (423,080) shares of Company Common and
three million five hundred thousand (3,500,000) shares of Company Preferred.  As
of the date of this  Agreement,  there were an aggregate  of three  million five
hundred thousand (3,500,000) shares of Company Common reserved for issuance upon
conversion  of Company  Preferred.  Company  Common and  Company  Preferred  are
referred to herein collectively as "Company Stock." The rights,  preferences and
privileges  of Company  Common  and  Company  Preferred  are as set forth in the
Company's Amended and Restated Articles of Incorporation.



                                       -6-



<PAGE>



        (b) As of the date of this  Agreement,  there were  outstanding  Company
Options to acquire nine hundred fifty-six thousand  fifty-five  (956,055) shares
of Company Common. As of the date of this Agreement,  there were an aggregate of
nine hundred fifty-six  thousand  fifty-five  (956,055) shares of Company Common
reserved for issuance upon the exercise of outstanding Company Options.

        (c) Other than as described in paragraphs  (a) and (b) above,  there are
no other  outstanding  shares of capital stock or other equity securities of the
Company and no other options, warrants, calls, conversion rights, commitments or
agreements  of any  character  to which the  Company  is a party or by which the
Company may be bound that do or may  obligate  the Company to issue,  deliver or
sell,  or cause  to be  issued,  delivered  or sold,  additional  shares  of the
Company's  capital stock or securities  convertible into or exchangeable for the
Company's capital stock or that do or may obligate the Company to grant,  extend
or enter into any such option,  warrant,  call, conversion right,  commitment or
agreement.

        (d) Of the issued and outstanding shares of Company Stock, no shares are
subject to repurchase or  redemption.  All  outstanding  shares of Company Stock
are,  and any shares of Company  Stock issued upon  exercise of Company  Options
(subject to receipt of the exercise prices as provided therein) will be, validly
issued,  fully  paid and  nonassessable  and not  subject to  preemptive  rights
created by statute,  the Company's  Articles of  Incorporation  or Bylaws or any
agreement  to which the Company is a party or by which the Company may be bound.
All  outstanding  securities of the Company have been issued in compliance  with
applicable federal and state securities laws.

        (e) Section 4.2 of the  Disclosure  Schedule  ("Schedule  4.2") contains
complete and accurate lists of, and the number of shares owned of record by, the
holders of outstanding  Company  Common and Company  Preferred and the number of
shares  subject to  Company  Options  and the  holders  of  outstanding  Company
Options,  including  in each  case the  addresses  of  record  of such  holders.
Schedule 4.2 is complete  and  accurate on the date hereof and, if required,  an
updated  Schedule 4.2 to be attached  hereto will be complete and accurate as of
the Closing Date.

        (f) Schedule  4.2  contains a complete  and accurate  list of each stock
option plan, stock appreciation rights or other  equity-related  stock incentive
plan of the Company and its Subsidiary.

        (g) Except for any restrictions  imposed by applicable federal and state
securities  laws,  there is no right of first refusal,  co-sale right,  right of
participation,  right of first offer,  option or other  restriction  on transfer
applicable to any shares of Company Stock.

        (h) Except as contemplated by this Agreement and the Stockholders Voting
Agreement   the  Company  is  not  a  party  or  subject  to  any  agreement  or
understanding,  and there is no  voting  trust,  proxy,  or other  agreement  or
understanding between or among any persons that affects or relates to the voting
or giving of written  consent  with respect to any  outstanding  security of the
Company, the election of directors, the appointment of officers or other actions
of the Company's Board or the management of the Company.

        4.3  Subsidiaries;  Equity  Investments.  Section 4.3 of the  Disclosure
Schedule  ("Schedule  4.3")  contains a complete and accurate list of all of the
Company's  Subsidiaries.  Except as set forth in Schedule  4.3, the Company does
not have and has never had any other Subsidiaries or companies


                                       -7-



<PAGE>



controlled  by the  Company  and does not own and has  never  owned  any  equity
interest  in, or  controlled,  directly or  indirectly,  any other  corporation,
partnership,  joint venture, trust, firm or other entity. Except as set forth in
Schedule  4.3,  the Company  owns all of the  outstanding  capital  stock of the
Subsidiary  listed  on  Schedule  4.3,  free and clear of any  claims,  liens or
encumbrances  except  where such  encumbrances  would have no  Material  Adverse
Effect on the  Company  and its  Subsidiary,  taken as a whole,  and no options,
warrants or other rights to acquire  shares of capital  stock of any  Subsidiary
are outstanding.

        4.4  Authority.  The  Company  has all  requisite  corporate  power  and
authority  to enter  into this  Agreement  and,  subject  only to the  requisite
approval  of this  Agreement  by the  Company's  stockholders,  to  perform  its
obligations  hereunder and consummate the transactions  contemplated hereby. The
vote required of the Company's  stockholders to duly approve the Merger and this
Agreement  is that number of shares as would  constitute:  (i) a majority of the
outstanding  shares  of  Company  Common,  voting  as a  single  class  and (ii)
sixty-six and  two-thirds  percent  (66-2/3%) of the  outstanding  owners of the
Company Preferred,  voting as a single class. The execution and delivery of this
Agreement,  the performance by the Company of its obligations  hereunder and the
consummation of the transactions  contemplated hereby have been duly and validly
authorized  by all  necessary  corporate  action  on the  part  of the  Company,
including approval of the Company Board,  subject only to the requisite approval
of this Agreement by the Company's  stockholders.  This Agreement is a valid and
binding obligation of the Company.

        4.5 No Conflict  with Other  Instruments.  The  execution,  delivery and
performance of this Agreement and the transactions  contemplated hereby (a) will
not result in any violation of, conflict with, constitute a breach, violation or
default (with or without notice or lapse of time, or both) under, give rise to a
right of termination, cancellation, forfeiture or acceleration of any obligation
or loss of any benefit under, or result in the creation or encumbrance on any of
the  properties or assets of the Company or its  Subsidiary  pursuant to (i) any
provision of the Company's  Amended and Restated  Articles of  Incorporation  or
Bylaws or the charter or other  organizational  documents of its Subsidiary,  as
the case may be, or (ii) any agreement, contract, understanding, note, mortgage,
indenture,  lease,  franchise,  license, permit or other instrument to which the
Company or its Subsidiary is a party or by which the properties or assets of the
Company or its Subsidiary is bound,  or (b) to the best knowledge of the Company
after reasonable inquiry,  conflict with or result in any breach or violation of
any statute, judgment, decree, order, rule or governmental regulation applicable
to the Company or its Subsidiary their respective properties or assets,  except,
in the  case  of  clauses  (a)(ii)  and  (b)  for  any of  the  foregoing  that,
individually or in the aggregate, has not had or would be reasonably expected to
have a Material  Adverse  Effect on the Company and its  Subsidiary,  taken as a
whole, or that could not result in the creation of any material lien,  charge or
encumbrance  upon any assets of the Company or its  Subsidiary or that could not
reasonably be expected to prevent,  materially  delay or  materially  burden the
transactions contemplated by this Agreement.

        4.6 Governmental Consents. No consent,  approval, order or authorization
of, or registration, declaration of, or qualification or filing with, any court,
administrative agency, commission, regulatory authority or other governmental or
administrative body or instrumentality, whether domestic or foreign, is required
by or with  respect to the  Company or its  Subsidiary  in  connection  with the
execution,  delivery  and  performance  of this  Agreement by the Company or the
consummation by the Company of the transactions  contemplated hereby, except for
(a) the filing of the  Certificate  of Merger with the  California  Secretary of
State and the Delaware Secretary of


                                       -8-



<PAGE>



State  (b) such  consents,  approvals,  orders,  authorizations,  registrations,
declarations,  qualifications  or filings as may be  required  under  federal or
state securities laws in connection with the transactions contemplated hereby.

        4.7  Financial  Statements.  The Company  has  previously  furnished  to
Meadowbrook a complete and accurate copy of the unaudited consolidated financial
statements  of the  Company  for the fiscal  year ended  December  31, 1997 (the
"Financial  Statements")  which comply as to form in all material  respects with
applicable  accounting  requirements.  The Financial Statements are complete and
correct in all  material  respects  and have been  prepared in  accordance  with
generally accepted accounting  principles ("GAAP") applied on a consistent basis
throughout  the  periods  indicated  and are  consistent  with each  other.  The
Financial Statements accurately set out and describe the financial condition and
operating results of the Company as of the dates, and for the periods, indicated
therein,  subject,  in the case of  unaudited  financial  statements,  to normal
year-end audit  adjustments.  At the date of the Financial  Statements and as of
the Closing Date,  except as set forth in the Disclosure  Schedule,  the Company
had no  liabilities  or  obligations,  secured or  unsecured  (whether  accrued,
absolute or  contingent  and  whether or not  required  to be  reflected  in the
Financial  Statements  under GAAP) not reflected in the Financial  Statements or
the accompanying  notes thereto except for liabilities and obligations that have
arisen in the  ordinary  course of business  prior to the date of the  Financial
Statements and which,  under GAAP,  would not have been required to be reflected
in the Financial  Statements and except for liabilities incurred in the ordinary
course of business  since the date of the Financial  Statements  which are usual
and normal in amount.  The  Company  maintains a standard  system of  accounting
established and  administered in accordance with GAAP.  Attached as Schedule 4.7
to the  Disclosure  Schedule is the Company's  budget for the twelve (12) months
ending December 31, 1998 that sets forth its budgeted revenues and expenses.

        4.8  Absence of  Changes.  Since the date of the  Financial  Statements,
except  as  otherwise  contemplated  by  this  Agreement  or  set  forth  in the
Disclosure  Schedule,  each of the Company and its  Subsidiary has conducted its
respective  business only in the ordinary and usual course and, without limiting
the generality of the foregoing:

        (a)  There  have  been  no  changes  in  the  condition   (financial  or
otherwise),  business,  net worth, assets,  properties,  employees,  operations,
obligations or liabilities of the Company and its Subsidiary,  taken as a whole,
which,  in the  aggregate,  have  had or may be  reasonably  expected  to have a
Material Adverse Effect on the Company and its Subsidiary, taken as a whole;

        (b) The Company has not nor has its Subsidiary issued, or authorized for
issuance,  or entered into any commitment to issue, any equity  security,  bond,
note or other security;

        (c) The Company has not nor has its Subsidiary  incurred additional debt
for borrowed  money,  or incurred  any  obligation  or  liability  except in the
ordinary  course of business  consistent with past practice and in any event not
in excess of twenty-five thousand dollars ($25,000) for any single occurrence;

        (d) The Company has not nor has its  Subsidiary  paid any  obligation or
liability,  or discharged,  settled or satisfied any claim, lien or encumbrance,
except for current  liabilities  in the ordinary  course of business  consistent
with past  practice  and in any event  not in  excess  of  twenty-five  thousand
dollars ($25,000) for any single occurrence;


                                       -9-



<PAGE>




        (e) The  Company  has not nor has its  Subsidiary  declared  or made any
dividend,  payment  or other  distribution  on or with  respect  to any share of
capital stock, other than, in the case of its Subsidiary, to the Company;

        (f) The Company has not nor has its  Subsidiary  purchased,  redeemed or
otherwise acquired or committed itself to acquire,  directly or indirectly,  any
share or shares of its capital stock;

        (g) The Company has not nor has its Subsidiary  mortgaged,  pledged,  or
otherwise  encumbered  any of its  assets or  properties,  except  for liens for
current taxes which are not yet delinquent and purchase-money  liens arising out
of the purchase or sale of services or products  made in the ordinary  course of
business  consistent  with  past  practice  and in any  event  not in  excess of
twenty-five  thousand  dollars  ($25,000)  for any single  item or  seventy-five
thousand dollars ($75,000) in the aggregate;

        (h) The Company has not nor has its Subsidiary disposed of, or agreed to
dispose  of, by sale,  lease,  license  or  otherwise,  any  asset or  property,
tangible or  intangible,  except in the ordinary  course of business  consistent
with past practice, and in each case for a consideration believed to be at least
equal to the fair value of such asset or property and in any event not in excess
of  twentyfive-thousand  dollars  ($25,000) for any single item or  seventy-five
thousand dollars ($75,000) in the aggregate;

        (i) The Company has not nor has its  Subsidiary  purchased  or agreed to
purchase or otherwise  acquire any securities of any  corporation,  partnership,
joint venture, firm or other entity;

        (j) The Company has not nor has its Subsidiary  made any  expenditure or
commitment  for the purchase,  acquisition,  construction  or  improvement  of a
capital asset,  except in the ordinary  course of business  consistent with past
practice  and in any  event  not  in  excess  of  twenty-five  thousand  dollars
($25,000) for any single item or seventy-five  thousand dollars ($75,000) in the
aggregate;

        (k)  The  Company  has  not  nor  has  its  Subsidiary  sold,  assigned,
transferred  or  conveyed,  or  committed  itself to sell,  assign,  transfer or
convey,  any  Proprietary  Rights (as  defined in Section ) except  pursuant  to
licenses in the ordinary course of business consistent with past practice;

        (l) The  Company has not nor has its  Subsidiary  adopted or amended any
bonus,  incentive,   profit-sharing,  stock  option,  stock  purchase,  pension,
retirement,  deferred-compensation,  severance, life insurance, medical or other
benefit plan, agreement, trust, fund or arrangement for the benefit of employees
of any kind  whatsoever,  nor entered into or amended any agreement  relating to
employment, services as an independent contractor or consultant, or severance or
termination pay, nor agreed to do any of the foregoing;

        (m) The  Company  has not nor has its  Subsidiary  effected or agreed to
effect any change in its directors, officers or key employees; and

        (n) The  Company  has not  effected  or  committed  itself to effect any
amendment or modification in its Amended and Restated  Articles of Incorporation
or Bylaws.



                                      -10-



<PAGE>



        4.9    Properties.

        (a) The Company does not nor does any  Subsidiary own any real property,
nor has it ever owned any real property. The Financial Statements reflect all of
the material real and personal  property used by the Company and its  Subsidiary
in  their  respective  businesses  or  otherwise  held  by the  Company  and its
Subsidiary,  except for (i)  property  acquired or  disposed of in the  ordinary
course  of  business  consistent  with  past  practice  of the  Company  and its
Subsidiary,  taken as a whole, since the date of the Financial  Statements,  and
(ii)  personal  property not required  under GAAP to be reflected  thereon.  The
Company  or its  Subsidiary  has good and  marketable  title to all  assets  and
properties listed in the Financial Statements as owned by the Company,  free and
clear of any  imperfections of title,  lien,  claim,  encumbrance,  restriction,
charge or equity of any nature  whatsoever,  except for liens for current  taxes
not yet delinquent or which have no Material Adverse Effect on the Company.

        (b) Section of the Disclosure  Schedule contains a complete and accurate
list of all material real property leased by the Company and its Subsidiary (the
"Properties"),  the name of the lessor and the date of the  lease.  The  Company
does  not nor  does  its  Subsidiary  have  any  options  to  purchase  any such
Properties  or  any  other  real  property.  To  the  Company's  knowledge,  the
Properties  are held  under  valid,  existing  and  enforceable  leases.  To the
Company's  knowledge  the  Properties  and the  operations of the Company or its
Subsidiary,  as the case may be, thereon do not violate any applicable  material
building  code,  zoning  requirement  or  classification,  or pollution  control
ordinance or statute relating to the Properties or to such operations.

        4.10   Environmental Matters.

        (a) To the Company's knowledge,  the Company and its Subsidiary are, and
at all times have been, in material  compliance with all applicable local, state
and federal statutes, orders, rules, ordinances, regulations, codes and policies
and  all  judicial  or  administrative  interpretations  thereof  (collectively,
"Environmental  Laws")  relating to pollution or protection of the  environment,
including,   without   limitation,   laws  relating  to  exposures,   emissions,
discharges,  releases or threatened releases of Hazardous Substances (as defined
below)  into or on land,  ambient  air,  surface  water,  groundwater,  personal
property or structures (including the protection,  cleanup, removal, remediation
or  damage  thereof),  or  otherwise  related  to the  manufacture,  processing,
distribution,   use,  treatment,  storage,  disposal,  transport,  discharge  or
handling of  Hazardous  Substances.  The Company has not nor has its  Subsidiary
received  any  notice of any  investigation,  claim or  proceeding  against  the
Company  or such  Subsidiary  relating  to  Hazardous  Substances  or any action
pursuant to or violation or alleged  violation under any  Environmental  Law. As
used in this Agreement, "Hazardous Substances" means any pollutant, contaminant,
material,  substance,  waste,  chemical or  compound  regulated,  restricted  or
prohibited  by  any  law,   regulation  or  ordinance  and   designated  by  any
governmental  agency  to  be  hazardous,  toxic,  radioactive,  biohazardous  or
otherwise a danger to health or the environment.

        (b) To the  Company's  knowledge,  the  Company  has  not  nor  has  its
Subsidiary disposed of any Hazardous Substances on or about such properties.

        (c) The Company and its Subsidiary have all material  permits,  licenses
and approvals  required by Environmental  Laws for the use and occupancy of, and
for all operations and activities conducted on, the Properties,  and the Company
and its Subsidiary are in full compliance with all


                                      -11-



<PAGE>



such  permits,  licenses  and  approvals,  and all such  permits,  licenses  and
approvals  were duly  issued,  are in full  force and  effect  except  where the
failure to do so has not  resulted  in and would not  reasonably  be expected to
result in a Material  Adverse  Effect,  and,  to the extent  necessary,  will be
transferred  to  Meadowbrook  at the Closing,  and will remain in full force and
effect as so transferred to Meadowbrook.

        4.11   Taxes.

        (a) For  purposes  of this  Agreement,  the  following  terms  have  the
following meanings: "Tax" (and, with correlative meaning, "Taxes" and "Taxable")
means any and all taxes,  including without limitation (i) any income,  profits,
alternative or add-on minimum tax, gross receipts,  sales, use, value-added,  ad
valorem,   transfer,   franchise,   profits,  license,   withholding,   payroll,
employment,  excise, severance, stamp, occupation, net worth, premium, property,
environmental  or windfall profit tax, custom,  duty or other tax,  governmental
fee or assessment or charge of any kind  whatsoever,  together with any interest
or any penalty, addition to tax or additional amount imposed by any governmental
entity  responsible  for the imposition of any such tax (domestic or foreign) (a
"Taxing  Authority"),  (ii) any  liability for the payment of any amounts of the
type  described  in  clause  (i)  above  as a result  of  being a  member  of an
affiliated, consolidated, combined or unitary group for any Taxable period or as
the result of being a transferee or successor  thereof,  and (iii) any liability
for the payment of any amounts of the type described in clause (i) or (ii) above
as a result of any express or implied obligation to indemnify any other person.

        (b) All Tax returns, statements,  reports and forms (including estimated
Tax  returns and reports and  information  returns and  reports)  required to be
filed with any Taxing  Authority with respect to any Taxable period ending on or
before the  Effective  Time,  by or on behalf of the  Company or its  Subsidiary
(collectively,  the "Company Returns"),  have been filed when due (including any
extensions  of such due date),  and all  amounts  shown to be due  thereon on or
before the Effective  Time have been paid on or before such date.  The Financial
Statements  fully accrue all actual and  contingent  liabilities  for Taxes with
respect to all periods  through the dates thereof in accordance  with GAAP.  The
Financial  Statements  (i) fully accrue  consistent  with past  practices and in
accordance  with GAAP all  actual  and  contingent  liabilities  for Taxes  with
respect to all periods  through the date of the  Financial  Statements  and (ii)
properly accrues  consistent with past practices and in accordance with GAAP all
liabilities  for Taxes  payable after the Balance Sheet Date with respect to all
transactions  and events occurring on or prior to such date. All information set
forth in the  notes to the  Financial  Statements  relating  to Tax  matters  is
consistent with GAAP.

        (c) To the Company's knowledge, no Tax liability has been incurred since
the date of the  Financial  Statements  other  than in the  ordinary  course  of
business and adequate  provision  has been made for all Taxes since that date in
accordance  with GAAP on at least a  quarterly  or, with  respect to  employment
taxes,  monthly  basis,  except  that  which has not had or would be  reasonably
expected to have a Material  Adverse  Effect on the Company and its  Subsidiary,
taken as a whole.  The Company and its Subsidiary  have withheld and paid to the
applicable financial  institution or Taxing Authority all amounts required to be
withheld,  except that which has not had or would be reasonably expected to have
a Material  Adverse Effect on the Company and its Subsidiary,  taken as a whole.
All Company Returns filed with respect to federal income tax returns for Taxable
years of the Company and its Subsidiary in the case of the United  States,  have
been  examined  and  closed  and copies of audit  reports  previously  have been
provided  to  Meadowbrook  or are  Company  Returns  with  respect  to which the
applicable period for assessment under applicable law, after giving effect


                                      -12-



<PAGE>



to  extensions  or  waivers,  has  expired.  The  Company  has  not  nor has its
Subsidiary  been  granted  any  extension  or  waiver of the  limitation  period
applicable to any Company Return.

        (d) To the Company's knowledge,  there is no claim, audit, action, suit,
proceeding or investigation now pending or threatened against or with respect to
the Company or its Subsidiary in respect of any Tax or assessment.  There are no
liabilities  for Taxes  with  respect  to any  notice of  deficiency  or similar
document of any Tax Authority  received by the Company or its  Subsidiary  which
have not been satisfied in full (including  liabilities for interest,  additions
to tax and penalties thereon and related expenses).  To the Company's knowledge,
none of the Company,  its  Subsidiary nor any person on behalf of the Company or
its  Subsidiary  has entered into any  agreement or consent  pursuant to Section
341(f) of the Code.  To the  Company's  knowledge,  there are no liens for Taxes
upon the assets of the Company or its Subsidiary  except liens for current Taxes
not yet due.  Except as may be required  as a result of the Merger,  the Company
has not nor has its  Subsidiary  been  required  to include  any  adjustment  in
Taxable income for any Tax period (or portion  thereof)  pursuant to Section 481
or 263A of the Code or any comparable  provision under state or foreign Tax laws
as a result of transactions,  events or accounting methods employed prior to the
Effective Time.

        4.12 Employees. The Company has provided Meadowbrook with a complete and
accurate list setting forth all employees,  scientific  advisors and consultants
of the Company and each  Subsidiary  as of the date hereof,  together with their
titles  or  positions,   dates  of  hire,  regular  work  location  and  current
compensation.  The  Company  does not have  nor  does  its  Subsidiary  have any
employment  contract  with any officer or employee  or any other  consultant  or
person which is not  terminable by it at will without  liability,  except as the
right of the Company or such  Subsidiary  to terminate its employees at will may
be limited by applicable  federal,  state or foreign law. Except as set forth in
the Disclosure Schedule,  the Company does not have nor does its Subsidiary have
any  deferred  compensation,  pension,  health,  profit  sharing,  bonus,  stock
purchase,  stock  option,   hospitalization,   insurance,   severance,  workers'
compensation,  supplemental unemployment benefits, vacation benefits, disability
benefits,  or any other  employee  pension  benefit (as defined in the  Employee
Retirement  Income  Security  Act of 1974  ("ERISA")  or  otherwise)  or welfare
benefit plan or obligation covering any of its officers or employees  ("Employee
Plans")  or any  informal  understanding  with  respect to the  foregoing.  Each
Employee Plan complies in all material respects with applicable laws, including,
without  limitation,  ERISA and the Code. Each Employee Plan has been maintained
in  material  compliance  with its  terms,  and all  applicable  ERISA and other
requirements   as  to  the  filing  of  reports,   documents  and  notices  with
governmental  agencies  and the  furnishing  of  documents  to  participants  or
beneficiaries have been satisfied.  The Company does not nor does its Subsidiary
maintain or has ever  maintained or  contributed to any Employee Plan subject to
Title IV of ERISA (relating to defined benefit plans).

        To the Company's knowledge, there are no controversies or labor disputes
or union  organization  activities  pending or threatened between the Company or
its Subsidiary and any of their employees.  To the Company's knowledge,  none of
the  employees  of the  Company  or its  Subsidiary  belongs  to  any  union  or
collective  bargaining  unit.  The  Company  and its  Subsidiary  have  complied
materially  with all  applicable  foreign,  state and federal  equal  employment
opportunity  and other laws and  regulations  related to  employment  or working
conditions, except that which has not had a would be reasonably expected to have
a Material Adverse Effect on the Company and its Subsidiary, taken as a whole.



                                      -13-



<PAGE>



        4.13 Compliance with Law. All material  licenses,  franchises,  permits,
clearances,  consents,  certificates  and other  evidences  of  authority of the
Company and its Subsidiary,  which are necessary to the conduct of the Company's
and its  Subsidiary,  respective  businesses  ("Permits")  are in full force and
effect and the Company is not nor is its  Subsidiary  in violation of any Permit
in any  material  respect.  Except  for  exceptions  have  not had or  would  be
reasonably  expected to have, a Material  Adverse  Effect on the Company and its
Subsidiary,  taken as a whole,  the businesses of the Company and its Subsidiary
have been conducted in accordance with all applicable laws, regulations,  orders
and other requirements of governmental authorities.

        4.14 Litigation. There is no claim, dispute, action, proceeding, notice,
order,  suit,  appeal or investigation,  at law or in equity,  pending or to the
Company's knowledge threatened,  against the Company or its Subsidiary or any of
their respective directors,  officers,  employees or agents, or involving any of
their  respective  assets or properties,  before any court,  agency,  authority,
arbitration panel or other tribunal,  except that which has not had or would not
reasonably be expected to have a Material  Adverse Effect on the Company and its
Subsidiary,  taken as a whole. The Company is not nor is its Subsidiary  subject
to any order, writ,  injunction or its decree of any court,  agency,  authority,
arbitration  panel or other  tribunal,  nor is the Company or its  Subsidiary in
default with respect to its notice, order, writ, injunction or decree.

        4.15  Contracts.  Section  4.15 of the  Disclosure  Schedule  contains a
complete and accurate list of each material  executory contract and agreement in
the following  categories to which the Company or its Subsidiary is a party,  or
by which the Company or its  Subsidiary is bound in any respect:  (a) agreements
for the  purchase,  sale,  lease  or  other  disposition  of  equipment,  goods,
materials, supplies, or capital assets, or for the performance of services which
are not  terminable  without  penalty on 30 days' notice,  in any case involving
more than fifty thousand dollars ($50,000);  (b) contracts or agreements for the
joint   performance   of  work  or  services,   and  all  other  joint  venture,
collaboration,  research,  or other agreements,  and grant requests or proposals
for research and development contracts in excess of one hundred thousand dollars
($100,000)  each;  (c)  management  or  employment   contracts,   consulting  or
scientific advisory contracts, collective bargaining contracts,  termination and
severance  agreements;  (d) notes,  mortgages,  deeds of trust, loan agreements,
security agreement,  guarantees,  debentures,  indentures, credit agreements and
other  evidences of  indebtedness;  (e) each Employee Plan  (including,  without
limitation,  any contracts or agreements with trustees,  insurance  companies or
others relating to any such employee benefit plan or arrangement); (f) warrants,
repurchase or other contracts or agreements  relating to the issuance of capital
stock or other equity interests of the Company or its Subsidiary;  (g) contracts
or agreements with any director,  officer, employee,  consultant or stockholder;
(h) patents,  licenses,  sublicenses,  royalty agreements and other contracts or
agreements  to which the  Company or its  Subsidiary  is a party,  or  otherwise
subject,  relating to Company's  Proprietary  Rights;  (i) personal  property or
capital  equipment leases and other rental,  use or service  arrangements of the
Company and its  Subsidiary  involving  payment  obligations  in excess of fifty
thousand dollars ($50,000) and which cannot be terminated  without penalty on 30
days' notice;  (j) any agreement pursuant to which the Company or its Subsidiary
has granted or may grant in the future,  to any party,  a source code license or
option or other  right to use or acquire  source  code;  and (k) other  material
contracts.

        The Company has not nor has its Subsidiary  nor, to the knowledge of the
Company,  has any of its  employees  entered  into  any  contract  or  agreement
containing  covenants  limiting  the right of the Company or its  Subsidiary  to
compete in any business or with any person. As used in this


                                      -14-



<PAGE>



Agreement,   the  terms  "contract"  and  "agreement"  include  every  contract,
agreement, commitment, understanding and promise, whether written or oral.

        4.16   No Default.

        (a) Each of the contracts,  agreements or other instruments  referred to
in Section is a legal,  binding  and  enforceable  obligation  by or against the
Company  or its  Subsidiary,  as the  case  may be,  subject  to the  effect  of
applicable bankruptcy, insolvency,  reorganization,  moratorium or other similar
federal  or state  laws  affecting  the  rights of  creditors  and the effect or
availability of rules of law governing specific  performance,  injunctive relief
or other equitable remedies. To the Company's knowledge,  no party with whom the
Company or its Subsidiary has an agreement or contract is in default  thereunder
or has  breached  any  term or  provision  thereof  which  has had or  would  be
reasonably  expected to have a Material  Adverse  Effect on the  business of the
Company and its Subsidiary, taken as a whole.

        (b) The Company  and its  Subsidiary,  in all  material  respects,  have
performed, or are now performing, the obligations of, and the Company is not nor
is its Subsidiary in material  default (or would by the lapse of time and/or the
giving of notice be in material default) in respect of, any contract,  agreement
or commitment  binding upon it or its assets or  properties  and material to the
conduct  of its  business.  No third  party  has  notified  the  Company  or its
Subsidiary  of any claim,  dispute  or  controversy  with  respect to any of the
executory  contracts of the Company or such Subsidiary,  as the case may be, nor
has the  Company  or its  Subsidiary  received  notice  or  warning  of  alleged
nonperformance,  delay in delivery or other  noncompliance by the Company or its
Subsidiary with respect to its obligations under any of those contracts.

        4.17 Major  Customers.  Schedule  4.17 of the  Disclosure  Schedule sets
forth a complete and correct  list of the twenty five (25) largest  customers of
the Company and its  Subsidiary in terms of sales revenue during the twelve (12)
month period  ended  December  31,  1997.  Except as set forth and  described in
Schedule 4.17, no customer  identified in the Disclosure  Schedule has given the
Company or its Subsidiary any notice terminating,  suspending or reducing in any
material respect, or specifying an intention to terminate,  suspend or reduce in
any material respect in the future,  or otherwise  reflecting a material adverse
change in, the business  relationship  between such customer and the Company and
its  Subsidiary  and, to the  knowledge of the Company and the  Securityholders,
there has not been any material  adverse change in the business  relationship of
the Company or its Subsidiary with any such customer since December 31, 1997.

        4.18   Proprietary Rights.

        (a) Section 4.18 of the  Disclosure  Schedule  sets forth a complete and
accurate list (the "Intellectual  Property Disclosure  Schedule") of all patents
and  applications  for patents,  trademarks,  trade names,  service  marks,  and
copyrights,  and applications therefor, owned by the Company and its Subsidiary.
Such list  specifies,  as  applicable:  (i) the title of the patent,  trademark,
trade  name,  service  mark,  copyright  or  application   therefor;   (ii)  the
jurisdiction by or in which such patent, trademark,  trade name, service mark or
copyright  has been issued or  registered  or in which an  application  has been
filed,  including the  registration or application  numbers;  and (iii) material
licenses,  sublicenses  and  similar  agreements  to which  the  Company  or its
Subsidiary is a party or pursuant to which any other party is authorized to use,
exercise or receive any benefit from any  Proprietary  Rights (as defined below)
of the Company or its Subsidiary.


                                      -15-



<PAGE>




        (b) To the Company's  knowledge,  the Company and its Subsidiary owns or
possesses or has the right to obtain  valid  licenses or other rights to use all
patents, patent applications, trademarks, trademark applications, trade secrets,
service  marks,  trade  names,  copyrights,   inventions,   drawings,   designs,
proprietary  know-how  or  information,  or other  rights with  respect  thereto
(collectively referred to as "Proprietary  Rights"),  used or currently proposed
to be used in the  business of the Company or such its  Subsidiary,  as the case
may be, and the same are sufficient to conduct the Company's or its Subsidiary's
business  as it  has  been  and is  now  being  conducted.  The  Company  or its
Subsidiary,  as the  case  may  be,  has  the  rights  to  use,  sell,  license,
sublicense,  assign, transfer,  convey or dispose of such Proprietary Rights and
the products, processes and materials covered thereby.

        (c) To the knowledge of the Company,  the  operations of the Company and
its Subsidiary do not conflict with or infringe,  and no one has asserted to the
Company that such operations conflict with or infringe,  any Proprietary Rights,
owned,  possessed  or used by any third  party.  There are no claims,  disputes,
actions, proceedings, suits or appeals pending against the Company or Subsidiary
with respect to any Proprietary Rights, and to the Company's knowledge, none has
been threatened against the Company or its Subsidiary. The Proprietary Rights of
the Company are free of any  unresolved  ownership  disputes with respect to any
third party and to the best  knowledge of the Company  there is no  unauthorized
use,  infringement or  misappropriation of any of such Proprietary Rights by any
third party,  including  any  employee or former  employee of the Company or its
Subsidiary nor is there any breach of any license, sublicense or other agreement
authorizing  another party to use such  Proprietary  Rights of the Company.  The
Company has not nor has its Subsidiary  has entered into any agreement  granting
any third  party the right to bring  infringement  actions  with  respect to, or
otherwise to enforce rights with respect to, any such  Proprietary  Right of the
Company which has had or would reasonably be expected to have a Material Adverse
Effect on its Company and its Subsidiary, taken as a whole.

        (d) The Intellectual  Property  Disclosure  Schedule contains a complete
and accurate list of any proceedings before any patent or trademark authority to
which the Company or its  Subsidiary is a party,  a  description  of the subject
matter of each proceeding, and the current status of each proceeding, including,
without limitation,  interferences, priority contests, opposition, and protests.
Such list includes any pending  applications  for reissue or  reexamination of a
patent. The Company or its Subsidiary has the exclusive right to file, prosecute
and maintain any such applications for patents, copyrights or trademarks and the
patents and registrations that issue therefrom.

        (e) All patents and  registered  trademarks,  service  marks,  and other
Company  product or service  identifiers  and registered  copyrights held by the
Company and its Subsidiary are valid and enforceable.

        (f) The  Company  and its  Subsidiary  have taken all other  measures it
deems reasonable to maintain the  confidentiality  of the Proprietary  Rights of
the Company used or proposed to be used in the conduct of its business the value
of which to the Company and its Subsidiary is contingent upon maintenance of the
confidentiality thereof.

        (g)  The  Company  and  its   Subsidiary   have  secured  valid  written
assignments  from all  consultants and employees who contributed to the creation
or development of the Company's or its  Subsidiary's  Proprietary  Rights of the
rights to such contributions that the Company or its Subsidiary does not already
own by operation of law.


                                      -16-



<PAGE>




        (h)  Except  as  set  forth  in  the  Intellectual  Property  Disclosure
Schedule,  each  employee and officer of and  consultant  to the Company and its
Subsidiary has executed a Proprietary  Information  and Inventions  Agreement or
other  nondisclosure  agreement and either a Non-Competition  Agreement or a Key
Employee  Agreement  material  in the  forms  provided  to  Meadowbrook.  To the
Company's,  knowledge, no employee or officer of or consultant to the Company is
in  violation  of any  material  term of any  employment  contract,  proprietary
information and inventions agreement,  non-competition  agreement,  or any other
contract or  agreement  relating  to the  relationship  of any such  employee or
consultant with the Company or any previous employer.

        4.19 Insurance.  The Company has provided Meadowbrook with copies of all
insurance  policies  to which the Company or its  Subsidiary  is a party or is a
beneficiary  or named insured.  All the insurable  properties of the Company and
its  Subsidiary  are insured  pursuant to  insurance  policies in full force and
effect.  There  have been no claims in excess of  twenty-five  thousand  dollars
($25,000)  asserted  under any of the  insurance  policies of the Company or its
Subsidiary in respect of all general liability,  professional liability,  errors
and omissions,  and worker's compensation and medical claims since the Company's
incorporation.

        4.20  Brokers or Finders.  Neither the Company nor any of its  officers,
directors,  employees  or  stockholders  has  employed  any  broker or finder or
incurred  any  liability  for  any  brokerage,   finder's  or  similar  fees  or
commissions in connection with this Agreement or the  transactions  contemplated
hereby.

        4.21  Related  Parties.  No officer or director of the  Company,  or any
affiliate of the Company or any such person, has, either directly or indirectly,
(a) a material interest in any corporation, partnership, firm or other person or
entity which  furnishes or sells services or products which are similar to those
furnished or sold by the Company or its Subsidiary, or (b) a beneficial interest
in any material  contract or agreement to which the Company or its Subsidiary is
a party or by which the Company or a Subsidiary may be bound.

        4.22 Certain  Advances.  There are no  receivables of the Company or its
Subsidiary   owing  from   directors,   officers,   employees,   consultants  or
stockholders of the Company or its  Subsidiary,  as the case may be, or owing by
any affiliate of any director or officer of the Company or its Subsidiary, other
than advances in the ordinary  course of business  consistent with past practice
to officers and employees for  reimbursable  business  expenses which are not in
excess of ten thousand dollars ($10,000) for any one individual.

        4.23 No  Misleading  Statements.  No  representation  or  warranty  made
herein, in the Disclosure Schedule or in the Appendices,  Schedules and Exhibits
attached  hereto or any written  statement  or  certificate  furnished  or to be
furnished to Meadowbrook  pursuant hereto or in connection with the transactions
contemplated  hereby (when read  together)  contains  any untrue  statement of a
material fact or omits a material fact necessary in order to make the statements
contained herein or therein,  in the light of the circumstances under which they
are made, not misleading.  The Company has disclosed to Meadowbrook all material
information  of which it is aware  relating  specifically  to the operations and
business  of the  Company as of the date of this  Agreement  or  relating to the
transactions contemplated by this Agreement.

        4.24 Company Proxy  Statement.  The information  supplied by the Company
for inclusion in the information statement to be sent to the stockholders of the
Company in connection with the


                                      -17-



<PAGE>



meeting  of the  Company  stockholders  to  consider  the Merger  (the  "Company
Stockholders Meeting") or in connection with any written consent of stockholders
of the Company (such proxy or information  statement as amended or  supplemented
is referred to herein as the "Company Proxy  Statement")  shall not, on the date
the Company Proxy Statement is first mailed to the Company stockholders,  at the
time of the  Company  Stockholders  Meeting,  or written  consent of the Company
stockholders and at the Effective Time,  contain any statement which is false or
misleading with respect to any material fact, or omit to state any material fact
necessary  in  order  to make  the  statements  made  therein,  in  light of the
circumstances under which they are made, not false or misleading. If at any time
prior to the Effective Time any event or information should be discovered by the
Company  which  should  be  set  forth  in an  amendment  to the  Company  Proxy
Statement,  the Company shall promptly inform Meadowbrook and Interset and shall
communicate  such  information  to the Company  stockholders  in an  appropriate
manner.  Notwithstanding  the  foregoing,  the Company makes no  representation,
warranty or covenant with respect to any information  supplied by Meadowbrook or
Interset which is contained in any of the foregoing documents.


                                    ARTICLE V

           REPRESENTATIONS AND WARRANTIES OF MEADOWBROOK AND INTERSET

        Meadowbrook  and Interset  represent  and warrant to the Company and the
Securityholders as follows:

        5.1 Organization. Each of Meadowbrook and Interset is a corporation duly
incorporated,  validly  existing and in good standing under the laws of Delaware
and has all requisite  corporate  power and authority to own,  lease and operate
its  properties  and to carry on its  business as now being  conducted.  Each of
Meadowbrook  and Interset is  qualified to do business as a foreign  corporation
and is in good standing  under the laws of each state or other  jurisdiction  in
which the nature of its business requires such  qualification,  except where the
failure to be so qualified or in good standing would not have a Material Adverse
Effect on  Meadowbrook  and its  subsidiaries,  taken as a whole.  The copies of
Meadowbrook's  Restated Certificate of Incorporation and Interset's  Certificate
of Incorporation and ByLaws that have been delivered to the Company are complete
and  correct  and in full force and  effect.  All of the issued and  outstanding
capital stock of Interset is owned by Meadowbrook.

        5.2    Capital Structure.

        (a) The  authorized  capital  stock of  Meadowbrook  consists of fifteen
million  (15,000,000) shares of Meadowbrook Common, $.01 par value, five million
(5,000,000)  shares  of Class B Common  Stock,  par value  $.01 per  share  (the
"Meadowbrook  Class B Common") and one million  (1,000,000)  shares of preferred
stock,  $.01 par value  ("the  Meadowbrook  Preferred").  As of the date of this
Agreement, there were issued and outstanding one million one hundred fifty-seven
thousand two hundred forty-four  (1,157,244) shares of Meadowbrook Common, seven
hundred seventy three thousand  (773,000)  shares of Meadowbrook  Class B Common
and no shares of Meadowbrook Preferred. As of the date of this Agreement,  there
were no shares of Meadowbrook  Common  reserved for issuance upon  conversion of
Meadowbrook Preferred. The rights, preferences and


                                      -18-



<PAGE>



privileges of the Meadowbrook  Common,  the  Meadowbrook  Class B Common and the
Meadowbrook Preferred are as set forth in the Meadowbrook's Restated Certificate
of Incorporation.

        (b) As of the date of this Agreement,  there were outstanding options to
acquire 63,334 shares of Meadowbrook Common (the "Meadowbrook  Options").  As of
the  date of this  Agreement,  there  were an  aggregate  of  41,667  shares  of
Meadowbrook  Common  reserved  for  issuance  upon the  exercise of  outstanding
Meadowbrook Options.

        (c) Other than as described  paragraphs (a) and (b) above,  there are no
other  outstanding  shares  of  capital  stock or  other  equity  securities  of
Meadowbrook  and  no  other  options,   warrants,   calls,   conversion  rights,
commitments or agreements of any character to which Meadowbrook is a party or by
which  Meadowbrook  may be bound that do or may obligate  Meadowbrook  to issue,
deliver or sell, or cause to be issued,  delivered or sold, additional shares of
Meadowbrook's  capital stock or securities  convertible into or exchangeable for
Meadowbrook's  capital  stock or that do or may obligate  Meadowbrook  to grant,
extend  or  enter  into  any  such  option,  warrant,  call,  conversion  right,
commitment or agreement.

        (d) Of the issued  and  outstanding  shares of  Meadowbrook  Common,  no
shares are  subject to  repurchase  or  redemption.  All  outstanding  shares of
Meadowbrook  Common  are,  and any  shares of  Meadowbrook  Common  issued  upon
exercise of any options  (subject to receipt of the exercise  prices as provided
therein) will be, validly issued,  fully paid and  nonassessable and not subject
to preemptive rights created by statute,  Meadowbrook's  Restated Certificate of
Incorporation  or Bylaws or any agreement to which  Meadowbrook is a party or by
which  Meadowbrook may be bound. All outstanding  securities of Meadowbrook have
been issued in compliance with applicable federal and state securities laws.

        (e) Except as contemplated by this Agreement and the Meadowbrook  Voting
Agreement,   Meadowbrook  is  not  a  party  or  subject  to  any  agreement  or
understanding,  and there is no  voting  trust,  proxy,  or other  agreement  or
understanding between or among any persons that affects or relates to the voting
or giving of  written  consent  with  respect  to any  outstanding  security  of
Meadowbrook,  the election of directors,  the  appointment  of officers or other
actions of Meadowbrook's Board or the management of Meadowbrook.


        5.3  Authority.  Each of  Meadowbrook  and  Interset  has all  requisite
corporate  power and  authority to enter into this  Agreement and to perform its
obligations  hereunder and consummate the transactions  contemplated hereby. The
execution and delivery of this Agreement, the performance by each of Meadowbrook
and  Interset  of  its  obligations   hereunder  and  the  consummation  of  the
transactions  contemplated  hereby have been duly and validly  authorized by all
necessary  corporate  action on the part of Meadowbrook and Interset,  including
approval of the Board of Directors of Meadowbrook (the "Meadowbrook  Board") and
Interset and the approval of the  stockholders  of Meadowbrook  and Interset (by
virtue of the written consent of the majority stockholder of Meadowbrook).  This
Agreement is a valid and binding obligation of each of Meadowbrook and Interset.

        5.4 No Conflict  with Other  Instruments.  The  execution,  delivery and
performance of this Agreement and the transactions  contemplated hereby (a) will
not result in any violation of, conflict with, constitute a breach, violation or
default (with or without notice or lapse of time, or both)


                                      -19-



<PAGE>



under,  give  rise  to a  right  of  termination,  cancellation,  forfeiture  or
acceleration  of any obligation or loss of any benefit  under,  or result in the
creation or encumbrance on any of the properties or assets of Meadowbrook or any
of its  subsidiaries,  including  Interset,  pursuant  to (i) any  provision  of
Meadowbrook's Restated Certificate of Incorporation or Interset's Certificate of
Incorporation or Bylaws, or (ii) any agreement, contract,  understanding,  note,
mortgage,  indenture,  lease, franchise,  license, permit or other instrument to
which  Meadowbrook  or  any of its  subsidiaries  is a  party  or by  which  the
properties or assets of Meadowbrook or any of its  subsidiaries is bound, or (b)
to the  knowledge of  Meadowbrook  after  reasonable  inquiry,  conflict with or
result in any breach or violation of any statute,  judgment, decree, order, rule
or governmental  regulation applicable to Meadowbrook or any of its subsidiaries
or their respective properties or assets, except, in the case of clauses (a)(ii)
and  (b)  for  any of the  foregoing  that  would  not,  individually  or in the
aggregate,  have a Material Adverse Effect on Meadowbrook and its  subsidiaries,
taken as a whole, or that could not result in the creation of any material lien,
charge or encumbrance  upon any assets of Meadowbrook or any of its subsidiaries
or  that  could  not  prevent,   materially  delay  or  materially   burden  the
transactions contemplated by this Agreement.

        5.5 Governmental Consents. No consent,  approval, order or authorization
of, or registration,  declaration or filing with, any governmental  authority is
required by or with respect to  Meadowbrook  or Interset in connection  with the
execution  and  delivery of this  Agreement by  Meadowbrook  and Interset or the
consummation  by  Meadowbrook  and  Interset  of the  transactions  contemplated
hereby, except for (a) the filing of the Certificate of Merger with the Delaware
Secretary of State and the California  Secretary of State and (b) such consents,
approvals, orders, authorizations,  registrations,  declarations, qualifications
or  filings  as may be  required  under  federal  or  state  securities  laws in
connection with the transactions set forth herein or which the failure to obtain
would not have a material  adverse effect on the  consummation by Meadowbrook of
the transactions contemplated hereby.

        5.6 SEC Documents. Meadowbrook has furnished to the Company complete and
accurate copies of Meadowbrook's  Annual Report on Form 10-K for the fiscal year
ended  June  30,  1997,  Meadowbrook's  Quarterly  Report  on Form  10-Q for the
quarters ended September 30, 1997 and December 31, 1997 and Meadowbrook's  Proxy
Statement  for its Annual  Meeting of  Stockholders  held on  November  20, 1997
("Meadowbrook's  SEC  Filings"),  each as filed with the Securities and Exchange
Commission under the Securities  Exchange Act of 1934, as amended (the "Exchange
Act"). As of their respective  filing dates,  Meadowbrook's SEC Filings complied
in all material  respects with the  requirements  of the Exchange Act and, as of
their  respective  filing dates,  Meadowbrook's  SEC Filings did not contain any
untrue  statement of a material fact or omit to state a material fact  necessary
to make the statements  made therein,  in the light of the  circumstances  under
which they were made, not misleading.  All other documents subsequently filed by
Meadowbrook  pursuant to Sections 13(a),  13(c), 14 or 15(d) of the Exchange Act
after the date of this Agreement and before the  termination of this  Agreement,
shall be incorporated by reference into the term "Meadowbrook's SEC Filings."

        5.7 Shares of Meadowbrook Common. The shares of Meadowbrook Common to be
issued   pursuant  to  the  Merger  will,  when  issued  and  delivered  to  the
Securityholders  and the shares of Meadowbrook  Common to be issued  pursuant to
the Converted  Company  Options  will,  when issued and delivered to the holders
thereof  on  payment  of  the  consideration   provided  for  therein,  be  duly
authorized, validly issued, fully paid and nonassessable.



                                      -20-



<PAGE>



        5.8 No Material  Adverse  Change.  Since  December 31,  1997,  except as
disclosed in Meadowbrook's SEC Filings,  there has not occurred:  (a) any change
that resulted or would  reasonably  be expected to result in a material  adverse
effect on Meadowbrook and its subsidiaries,  taken as a whole; (b) any amendment
or change in Meadowbrook's  Restated  Certificate of Incorporation or Bylaws; or
(c) any damage to, destruction or loss of any assets of Meadowbrook  (whether or
not  covered by  insurance)  that  resulted or would  reasonably  be expected to
result in a material adverse effect on Meadowbrook and its  subsidiaries,  taken
as a whole.

        5.9  Nasdaq  National  Market.   As  of  the  date  of  this  Agreement,
Meadowbrook is authorized for quotation on the Nasdaq National Market,  provided
however,  that any subsequent  change in  Meadowbrook's  listing status with the
Nasdaq National  Market shall not be considered a breach of this  representation
nor be deemed to have a Material  Adverse Effect on Meadowbrook  for purposes of
this Agreement.

        5.10 Brokers or Finders.  Neither  Meadowbrook  nor any of its officers,
directors  or  employees  has  employed  any  broker or finder or  incurred  any
liability  for  any  brokerage,  finder's  or  similar  fees or  commissions  in
connection with this Agreement or the transactions contemplated hereby.

        5.11  Disclosure.  None of the  information  provided by  Meadowbrook or
Interset and contained in the Company Proxy Statement,  at the time such Company
Proxy Statement was first delivered to the Company  Stockholders and at the time
of the  Company  Stockholders'  Meeting,  or  written  consent  of  the  Company
Stockholders,  and  none of the  representations  and  warranties  made or other
information  provided  by  Meadowbrook  or  Interset  in this  Agreement  or any
Schedule or Exhibit attached  hereto,  or in any other  certificate  document or
instrument  furnished by Meadowbrook or Interset either pursuant to the terms of
this  Agreement  or in  connection  with the  transactions  contemplated  hereby
contains  or will  contain  at the  Effective  Time any  untrue  statement  of a
material  fact or omits or will omit to state at the  Effective  Time a material
fact known to Meadowbrook  necessary in order to make the  statements  contained
herein or therein, in light of the circumstances under which they were made, not
misleading.


                                   ARTICLE VI

                       CONDUCT PRIOR TO THE EFFECTIVE TIME

        6.1 Conduct of Business of the Company.  During the period from the date
of this  Agreement and continuing  until the earlier of the  termination of this
Agreement and the Effective  Time, the Company agrees (except as contemplated by
this  Agreement or to the extent that  Meadowbrook  shall  otherwise  consent in
writing) to carry on its business in the usual,  regular and ordinary  course in
substantially  the same  manner as  heretofore  conducted,  to pay its debts and
Taxes when due, to pay or perform other obligations when due, and, to the extent
consistent  with  such  business,  to use all  commercially  reasonable  efforts
consistent  with past  practice  and  policies  to  preserve  intact its present
business  organization,  keep available the services of its present officers and
key  employees  and  preserve  its  relationships  with  customers,   suppliers,
distributors, licensors, licensees, and others having business dealings with it,
all with the goal of preserving  unimpaired its goodwill and ongoing  businesses
at the Effective Time (and to cause its Subsidiary to do the same).


                                      -21-



<PAGE>




        Following the date of this Agreement,  the Company shall promptly notify
Meadowbrook  of any  materially  negative  event  related to the Company and its
Subsidiary or the business of the Company and its Subsidiary,  taken as a whole.
Without  limiting  the  foregoing,  except  as  expressly  contemplated  by this
Agreement,  the  Company  shall not,  and shall not permit  its  Subsidiary  to,
without the prior written consent of Meadowbrook:

        (a)  Enter  into  any  material  commitment  or  transaction  not in the
ordinary course of business consistent with past practice;

        (b)  Transfer  to any  person  or  entity  any  material  rights  to the
Proprietary  Rights of the  Company,  other than  pursuant  to  licenses  in the
ordinary course of business consistent with past practice;

        (c) Enter into any material  agreements (or material amendments thereto)
pursuant to which any unrelated third party is granted  marketing,  distribution
or similar  rights of any type or scope  with  respect  to any  products  of the
Company  or its  Subsidiary  other  than  in the  ordinary  course  of  business
consistent with past practice;

        (d) Amend or otherwise modify, except in the ordinary course of business
consistent  with past  practice,  or violate the  material  terms of, any of the
agreements set forth or described in the Disclosure Schedule;

        (e)  Commence any material litigation;

        (f)  Declare,  set  aside  or pay any  dividends  on or make  any  other
distributions  (whether  in cash,  stock or  property)  in respect of any of its
capital stock, or split, combine or reclassify any of its capital stock or issue
or authorize  the issuance of any other  securities in respect of, in lieu of or
in substitution  for shares of its capital stock or other equity  interests,  or
repurchase,  redeem or otherwise acquire, directly or indirectly,  any shares of
its capital stock (or options,  warrants or other rights exercisable  therefor),
except in connection with the restructuring of its indebtedness;

        (g) Except for the issuance of shares of Company  Stock upon exercise of
presently  outstanding Company Options or upon conversion of outstanding Company
Preferred,  issue, grant,  deliver or sell or authorize or propose the issuance,
grant,  delivery or sale of, or purchase or propose the  purchase of, any shares
of its capital stock or securities  convertible into, or subscriptions,  rights,
warrants  or options to  acquire,  or other  agreements  or  commitments  of any
character   obligating  it  to  issue  any  such  shares  or  other  convertible
securities, except in connection with the restructuring of its indebtedness;

        (h) Cause or permit any amendments to its Amended and Restated  Articles
of Incorporation or Bylaws (or other charter  documents)  except as contemplated
by this Agreement;

        (i) Acquire by merging or  consolidating  with,  or by  purchasing  any
assets or equity  securities  of, or by any other  manner,  any  business or any
corporation, partnership, association or other business organization or division
thereof,  or  otherwise  acquire or agree to acquire  any assets in an amount in
excess of fifty thousand dollars  ($50,000) in the case of a single  transaction
or in excess of one hundred thousand dollars  ($100,000) in the aggregate in any
30-day period;



                                      -22-



<PAGE>



        (j) Sell,  lease,  license or otherwise dispose of any of its properties
or assets in excess of fifty thousand dollars ($50,000),  except in the ordinary
course of business consistent with past practice;

        (k) Except as contemplated by Section 7.12 of this Agreement,  incur any
indebtedness  for borrowed money or guarantee any such  indebtedness or issue or
sell any of its debt securities or guarantee any debt securities of others;

        (l)  Grant any  severance  or  termination  pay (i) to any  director  or
officer  or (ii) to any other  employee  other  than  pursuant  to the  existing
agreements of the Company or its Subsidiary;

        (m)  Adopt  or amend  any  employee  benefit  plan,  or  enter  into any
employment  contract,  extend  employment  offers to any person whose  aggregate
annual base salary would exceed fifty thousand dollars ($50,000) pay or agree to
pay any special bonus or special  remuneration to any director or employee other
than in  connection  with normal  annual  bonus and salary  adjustments  for all
non-officers and directors upon consultation  with Meadowbrook,  or increase the
salaries or wage rates of its other  employees,  except as  consistent  with the
ordinary course of business consistent with past practice;

        (n) Revalue any of its assets, including without limitation writing down
the value of inventory or writing off notes or accounts  receivable,  other than
in the ordinary course of business consistent with past practice;

        (o) Pay,  discharge  or satisfy,  in an amount in excess of  twenty-five
thousand  dollars  ($25,000) (in any one case) or seventy-five  thousand dollars
($75,000) (in the  aggregate),  any claim,  liability or  obligation  (absolute,
accrued,  asserted  or  unasserted,  contingent  or  otherwise),  other than the
payment,  discharge  or  satisfaction  in the  ordinary  course of  business  of
liabilities  reflected or reserved  against in the Financial  Statements or that
arose in the  ordinary  course of business  subsequent  to December  31, 1997 or
unless payment of such claim,  liability or obligation is due in accordance with
its terms or expenses  consistent with the provisions of this Agreement incurred
in connection with the transactions  contemplated hereby and is not in excess of
twenty-five thousand dollars ($25,000);

        (p) Make or change any material  election in respect of Taxes,  adopt or
change  any  accounting  method in  respect  of Taxes,  enter  into any  closing
agreement, settle any claim or assessment in respect of Taxes, or consent to any
extension  or  waiver  of the  limitation  period  applicable  to any  claim  or
assessment in respect of Taxes; or

        (q) Take,  or agree in writing or otherwise to take,  any of the actions
described in Sections  6.1(a)  through  6.1(p)  above,  or any other action that
would  prevent the Company from  performing  or cause the Company not to perform
its covenants hereunder.

        6.2    No Solicitation.

        (a) Until the earlier of the Effective  Time and the date of termination
of this Agreement, the Company agrees that it shall not, and shall not authorize
or  permit  of its  Subsidiary  or any  of  its  or its  Subsidiary's  officers,
directors,  agents,  representatives  or affiliates to,  directly or indirectly,
take any of the following  actions with any party other than Meadowbrook and its
designees: solicit,


                                      -23-



<PAGE>



initiate,  facilitate or encourage (including by way of furnishing or disclosing
non-public information) any inquiries or the making of any proposal with respect
to any merger, consolidation or other business combination involving the Company
or its Subsidiary or acquisition of any kind of material  portion of the capital
stock or assets of the Company or its Subsidiary (an "Acquisition  Transaction")
or negotiate,  explore or otherwise  communicate in any way with any third party
with  respect  to any  Acquisition  Transaction  or enter  into  any  agreement,
arrangement  or  understanding  with respect to an  Acquisition  Transaction  or
requiring  it to abandon,  terminate,  or fail to  consummate  the Merger or any
other  transactions  contemplated  by this  Agreement,  or make or authorize any
statement,   recommendation  or  solicitation  in  support  of  any  Acquisition
Transaction with any third party other than Meadowbrook and Interset.

        (b) If (i) the  Company  or its  representatives  receives  prior to the
earlier of the Effective  Time and the  termination of this Agreement any offer,
letter of intent or other  proposal,  as applicable,  relating to an Acquisition
Transaction or any request for non-public information relating to the Company in
connection  with an  Acquisition  Transaction  or for access to the  properties,
books or records of the Company or its  Subsidiary  by any person or entity that
informs the Company Board that it is considering making, or has made, a proposal
relating to an  Acquisition  Transaction,  the  Company  shall  promptly  notify
Meadowbrook  orally  and in writing  thereof,  including  information  as to the
identity of the offeror or the party  making any such offer or proposal  and the
specific  terms of such  offer or  proposal,  as the case may be, and such other
information related thereto as Meadowbrook may reasonably request.

        6.3 Conduct of Business of Meadowbrook.  During the period from the date
of this  Agreement and continuing  until the earlier of the  termination of this
Agreement and the Effective Time,  Meadowbrook agrees (except as contemplated by
this  Agreement  or to the extent that the Company  shall  otherwise  consent in
writing,  which  consent  shall  not  be  unreasonably   withheld,   delayed  or
conditioned) to carry on its business in the usual,  regular and ordinary course
in substantially the same manner as heretofore  conducted,  to pay its debts and
Taxes when due, to pay or perform other obligations when due, and, to the extent
consistent  with  such  business,  to use all  commercially  reasonable  efforts
consistent  with past  practice  and  policies  to  preserve  intact its present
business  organization,  keep available the services of its present officers and
key  employees  and  preserve  its  relationships  with  customers,   suppliers,
distributors, licensors, licensees, and others having business dealings with it,
all with the goal of preserving  unimpaired its goodwill and ongoing  businesses
at the Effective Time.  Following the date of this Agreement,  Meadowbrook shall
promptly  notify  the  Company  of any  materially  negative  event  related  to
Meadowbrook or its business. Notwithstanding the foregoing, prior to the Closing
Date,  Meadowbrook  further  agrees  not to take  any of the  following  actions
(except as  contemplated  by this  Agreement  or to the extent  that the Company
shall  otherwise  consent in writing,  which consent  shall not be  unreasonably
withheld, delayed or conditioned):

        (a)  Cause or permit  any  amendments  to its  Restated  Certificate  of
Incorporation or Bylaws (or other charter  documents)  except as contemplated by
this Agreement;

        (b)  Acquire by merging or  consolidating  with,  or by  purchasing  any
assets or equity  securities  of, or by any other  manner,  any  business or any
corporation, partnership, association or other business organization or division
thereof,  or  otherwise  acquire or agree to acquire  any assets in an amount in
excess of one hundred thousand dollars ($100,000) in the case of a single


                                      -24-



<PAGE>



transaction  or in excess of three hundred  thousand  dollars  ($300,000) in the
aggregate in any 30-day period;

        (c) Sell,  lease,  license or otherwise dispose of any of its properties
or assets in excess of three hundred thousand dollars ($300,000),  except in the
ordinary course of business consistent with past practice; or

        (d) Issue, grant,  deliver or sell or authorize or propose the issuance,
grant,  delivery or sale of, or purchase or propose the  purchase of, any shares
of its capital stock or securities  convertible into, or subscriptions,  rights,
warrants  or options to  acquire,  or other  agreements  or  commitments  of any
character   obligating  it  to  issue  any  such  shares  or  other  convertible
securities,  except for the  issuance of shares of  Meadowbrook  Common upon the
exercise of presently outstanding Meadowbrook Options in an amount not to exceed
thirty  thousand  (30,000)  shares or to effect any stock split or  combination,
exchange or readjustment of shares.


                                   ARTICLE VII

                              ADDITIONAL AGREEMENTS

        7.1 Approval of the Company Stockholders.  Prior to the Closing Date and
at the earliest  practicable  date  following the date hereof,  the Company will
solicit  written  consents from its  stockholders  seeking,  or hold the Company
Stockholders Meeting for the purpose of seeking, approval of this Agreement, the
Merger and  related  matters.  If the  Company  holds the  Company  Stockholders
Meeting,  the  Board of  Directors  will  solicit  proxies  from  the  Company's
stockholders  to vote  such  stockholders'  shares at the  Company  Stockholders
Meeting.  In soliciting such written consent or proxies,  the Board of Directors
of the Company  will  recommend  to the  stockholders  of the Company  that they
approve this  Agreement and the Merger and shall use its  reasonable  efforts to
obtain the approval of the  stockholders  of the Company  entitled to vote on or
consent to this  Agreement  and the Merger in  accordance  with the CGCL and the
Company's Articles of Incorporation. The Board of Directors of the Company shall
not take  any  action  to amend or  nullify  its  resolution  approving,  or its
recommendation   to  stockholders   of,  this  Agreement  and  the  transactions
contemplated hereby.

        7.2 Preparation of Company Proxy Statement.  The Company and Meadowbrook
will prepare as soon as reasonably  practicable  the Company Proxy  Statement in
form and substance  reasonably  acceptable to  Meadowbrook,  with respect to the
solicitation  of written  consents  and/or proxies from the  stockholders of the
Company to approve this Agreement,  the Merger and related matters.  The Company
Proxy  Statement  shall be in such form and contain  such  information  so as to
permit compliance by Meadowbrook with the requirements of Regulation D under the
Securities Act of 1933, as amended (the "Securities Act") in connection with the
issuance of shares of Meadowbrook Common in the Merger.

        7.3 Access to Information; Interim Financial Information. Subject to any
applicable contractual  confidentiality  obligations (which each party shall use
all  commercially  reasonable  efforts to cause to be waived)  each party  shall
afford the other party and its accountants,  counsel and other  representatives,
reasonable  access during normal  business  hours during the period prior to the
Effective  Time  to (a)  all of its and  its  subsidiaries'  properties,  books,
contracts, agreements


                                      -25-



<PAGE>



and records, and (b) all other information  concerning the business,  properties
and personnel (subject to restrictions  imposed by applicable law) of it and its
subsidiaries as the others may reasonably  request.  No information or knowledge
obtained in any investigation pursuant to this Section shall affect or be deemed
to modify any  representation or warranty  contained herein or the conditions to
the obligations of the parties to consummate the Merger.  Promptly following the
end of each month between the date of this  Agreement and the Closing Date,  the
Company shall  prepare and furnish to  Meadowbrook  financial  statements of the
Company as of and for the month and year-to-date  periods ending on the last day
of such month,  all  prepared in a manner  consistent  with the  Company's  past
practice.

        7.4  Confidentiality.  Each of the parties  hereto  hereby agrees to use
reasonable efforts to assure that any non-public information that such party may
obtain from another party in connection with this Agreement will be confidential
and, unless and until the Closing occurs,  such party will not disclose any such
information  to any other Person  (other than on a  "need-to-know"  basis to its
stockholders,   directors,  managers,  officers,  partners  and  employees,  and
representatives  of its advisers,  investors and lenders whose knowledge thereof
is necessary in order to facilitate the  consummation of the Merger) or use such
information to the detriment of the other parties;  provided that (a) such party
may use and disclose any such  information  once it has been publicly  disclosed
(other than by such party in breach of its  obligations  under this Section ) or
which rightfully has come into the possession of such party (other than from the
other  parties),  and (b) to the extent that such party may,  in the  reasonable
opinion of its counsel,  be compelled by applicable law or any legal requirement
to disclose any of such information, such party may disclose such information if
it will have used all  reasonable  efforts,  and will  have  afforded  the other
parties the  opportunity,  to obtain an appropriate  protective  order, or other
satisfactory assurance of confidential treatment,  for the information compelled
to be disclosed. The obligation by the parties to hold information in confidence
pursuant to this Section will be satisfied if such party exercises the same care
with  respect  to  such  information  as  it  would  exercise  to  preserve  the
confidentiality of its own similar  information.  In the event of termination of
this Agreement,  each party will cause to be delivered to the other,  and retain
no copies of, any documents,  work papers and other  materials  obtained by such
party or on its behalf from the other  parties,  whether so  obtained  before or
after the  execution  hereof as long as such  documents,  work  papers and other
materials do not fall within the  exceptions set forth in clauses (a) and (b) of
this subsection.

        7.5  Expenses.  All fees and expenses  incurred in  connection  with the
Merger including, without limitation, all legal, accounting, financial advisory,
consulting and all other fees and expenses of third parties  incurred by a party
in connection with the negotiation and  effectuation of the terms and conditions
of this  Agreement  and  the  transactions  contemplated  hereby,  shall  be the
obligation of the respective  party incurring such fees and expenses;  provided,
however, at the Closing,  Meadowbrook shall pay the reasonable fees and expenses
of Cooley Godward LLP, incurred in their  representation  of the Company,  in an
amount not to exceed twenty five thousand dollars ($25,000).

        7.6 Public  Disclosure.  Unless  otherwise  required by law  (including,
without  limitation,  securities  laws) or, as to Meadowbrook,  by the rules and
regulations  of the  Nasdaq  Stock  Market,  prior  to the  Effective  Time,  no
disclosure  (whether or not in response  to an  inquiry) of the  discussions  or
subject  matter  of this  Agreement  shall be made by any  party  hereto  unless
approved by  Meadowbrook  and the Company  prior to release,  provided that such
approval shall not be unreasonably withheld.


                                      -26-



<PAGE>




        7.7  Reasonable  Efforts.  Subject to the terms and  conditions  of this
Agreement,  each of the parties  hereto  shall use all  commercially  reasonable
efforts to take promptly, or cause to be taken promptly,  all actions, and to do
promptly, or cause to be done promptly all things reasonably  necessary,  proper
or advisable  under  applicable  laws and  regulations  to  consummate  and make
effective the transactions contemplated hereby, to obtain all necessary waivers,
consents and approvals, to effect all necessary registrations and filings and to
remove any injunctions or other  impediments or delays,  legal or otherwise,  in
order to consummate and make  effective the  transactions  contemplated  by this
Agreement  for the  purpose of  securing  to the  parties  hereto  the  benefits
contemplated  by  this   Agreement;   provided  that  neither  the  Company  nor
Meadowbrook  shall be required to agree to any divestiture by Meadowbrook or the
Company,  as  may  be  applicable,  or any  of  Meadowbrook's  or the  Company's
subsidiaries or affiliates of shares of capital stock or of any business, assets
or properties of Meadowbrook or its affiliates or the Company,  its subsidiaries
or its affiliates,  or the imposition of any material  limitation on the ability
of any of them to conduct their businesses or to own or exercise control of such
assets, properties and stock.

        7.8 Conduct;  Notification of Certain  Matters.  Each of Meadowbrook and
the Company shall use all commercially  reasonable  efforts to not take, or fail
to take, any action that from the date hereof through the Closing would cause or
constitute  a  breach  of  any of its  respective  representations,  warranties,
agreements  and  covenants set forth in this  Agreement.  The Company shall give
prompt written notice to Meadowbrook,  and Meadowbrook shall give prompt written
notice to the Company, of (a) the occurrence or non-occurrence of any event, the
occurrence  or  non-occurrence  of  which  causes  or is  likely  to  cause  any
representation   or  warranty  of  the  Company  or   Meadowbrook  or  Interset,
respectively,  contained  in this  Agreement to be untrue or  inaccurate  in any
material  respect at or prior to the  Effective  Time and (b) any failure of the
Company  or  Meadowbrook  or  Interset,  as the case may be, to  comply  with or
satisfy in any  material  respect any  covenant,  condition  or  agreement to be
complied with or satisfied by it hereunder; provided, however, that the delivery
of any notice  pursuant to this Section shall not limit or otherwise  affect the
other party's right to rely on the  representations and warranties herein or any
the other remedies available to the party receiving such notice.

        7.9 Tax-Free Reorganization.  Meadowbrook and the Company shall each use
all  commercially  reasonable  efforts  to cause the  Merger to be  treated as a
reorganization  within the  meaning of Section  368 of the Code,  including  the
execution of tax representation  certificates  standard for transactions of this
type.

        7.10  Blue  Sky  Laws.  Meadowbrook  shall  take  such  steps  as may be
necessary to comply with the securities  and blue sky laws of all  jurisdictions
which  are  applicable  to the  issuance  of the  shares of  Meadowbrook  Common
pursuant  hereto.  The  Company  shall  use all  reasonable  efforts  to  assist
Meadowbrook  as may be reasonably  necessary to comply with the  securities  and
blue sky laws of all  jurisdictions  which are applicable in connection with the
issuance of the shares of Meadowbrook Common pursuant hereto.

        7.11 Compliance with Exchange Act. As promptly as practicable  after the
date hereof, Meadowbrook shall, in accordance with Section 14(c) of the Exchange
Act,  file  with the  Securities  and  Exchange  Commission  and  distribute  to
stockholders  of  Meadowbrook  an  Information   Statement  which  contains  the
information  required by Regulation 14C under the Exchange Act. Such Information
Statement shall be referred to as the "Meadowbrook Information Statement."



                                      -27-



<PAGE>



        7.12 Meadowbrook  Funding.  Prior to the Closing Date Meadowbrook agrees
to advance  funding to the  Company in an  aggregate  amount not to exceed  five
hundred thousand dollars  ($500,000) in accordance with the terms and conditions
of the Secured Bridge Financing Note attached hereto as Exhibit C.

        7.13  Meadowbrook  Voting  Agreement.  The Meadowbrook  Voting Agreement
shall be entered into by the parties thereto.

        7.14 Registration Rights Agreement.  Meadowbrook and the Securityholders
shall enter into the Registration Rights Agreement attached hereto as Exhibit D.

        7.15 Additional Documents and Further Assurances.  Each party hereto, at
the reasonable request of the other party hereto, shall execute and deliver such
other  instruments  and do and  perform  such  other  acts and  things as may be
reasonably  necessary or desirable for effecting  completely the consummation of
this Agreement and the transactions contemplated hereby.

        7.16  Indemnification.  Meadowbrook  shall guarantee and shall cause the
Surviving  Corporation  to maintain and perform in the same manner the Company's
existing indemnification provisions with respect to present and former directors
and  officers  of the  Company  for all  losses,  claims,  damages,  expenses or
liabilities  arising out of actions or omissions or alleged actions or omissions
occurring at or prior to the Effective Time to the extent  permitted or required
under  applicable  law  and the  Company's  Amended  and  Restated  Articles  of
Incorporation  and  Bylaws  in  effect  as of the  date  hereof  (to the  extent
consistent  with  applicable  law),  for a period of not less than six (6) years
after the Effective Time.

        7.17  Waiver of  Rights of First  Refusal.  Each  Securityholder  hereby
waives,  as  of  the  Effective  Time,  the  Right  of  First  Refusal  and  any
corresponding  notice requirements set forth in Section 4 of the Investor Rights
Agreement,  dated April 17, 1997 between the Company and certain shareholders of
the Company  (the  "Investor  Rights  Agreement")  arising  from any issuance of
equity  securities  by the Company prior to the date hereof,  including  without
limitation   the  issuance  of  warrants  to  Frederick   Adler   ("Adler")  and
Euro-America  II, L.P.  ("EAII") in connection with loans to the Company made by
Adler and EAII. The  Securityholders  and the Company further agree to cause the
termination of the Investor Rights Agreement as of the Effective Time.


                                  ARTICLE VIII

                            CONDITIONS TO THE MERGER

        8.1 Conditions to  Obligations  of Each Party to Effect the Merger.  The
respective  obligations of each party to this Agreement to consummate the Merger
shall be subject to the satisfaction at or prior to the Closing of the following
conditions:

        (a)  Stockholder  Approval.  This Agreement shall have been approved and
adopted by the requisite vote of the stockholders of the Company.



                                      -28-



<PAGE>



        (b) No Injunctions or Restraints;  Illegality.  No temporary restraining
order, preliminary or permanent injunction or other order issued by any court of
competent  jurisdiction  or other legal or regulatory  restraint or  prohibition
preventing the consummation of the Merger shall be in effect.

        8.2 Additional Conditions to Obligations of the Company. The obligations
of the Company to consummate  the Merger and the  transactions  contemplated  by
this Agreement  shall be subject to the  satisfaction at or prior to the Closing
of each of the  following  conditions,  any of which may be waived,  in writing,
exclusively by the Company:

        (a) Representations  and Warranties.  The representations and warranties
of  Meadowbrook  and  Interset  contained  in this  Agreement  shall be true and
correct on the date hereof and on and as of the Closing  Date, as though made on
and as of the Closing Date (except for representations and warranties made as of
a specified date, which need be true and correct only as of the specified date),
except  for  changes   contemplated  by  this  Agreement  and  except  for  such
inaccuracies  that,  considered  collectively,   have  not  had  and  would  not
reasonably  be expected to have a Material  Adverse  Effect on  Meadowbrook  (it
being  understood  that,  for  purposes  of  determining  the  accuracy  of such
representations  and  warranties,   all  "Material  Adverse  Effect"  and  other
materiality  qualifications  contained in such  representations  and  warranties
shall be disregarded).

        (b)  Agreements and  Covenants.  Each of Meadowbrook  and Interset shall
have  performed or complied in all material  respects  with all  agreements  and
covenants  required by this  Agreement to be performed or complied with by it on
or prior to the Effective Time.

        (c) Officer's  Certificate.  Each of Meadowbrook and Interset shall have
furnished the Company with a certificate dated the Closing Date signed on behalf
of it by the  Chief  Executive  Officer  or  President  to the  effect  that the
conditions set forth in Sections 7.2(a) and (b) have been satisfied.

        (d)  Meadowbrook  Voting  Agreement.  The  relevant  parties  shall have
entered into the Meadowbrook Voting Agreement substantially in the form attached
hereto as Exhibit B.

        (e)  Board  of  Directors.  The  size  of  the  Board  of  Directors  of
Meadowbrook  shall  have been  increased  to six (6)  members  and the three (3)
individuals  nominated by the Company (and reasonably acceptable to Meadowbrook)
shall have been appointed to the Board of Directors of Meadowbrook.

        (f) Restructuring. The Securityholders,  on behalf of the Company, shall
have caused to be paid such amounts as may be necessary to reduce the  Company's
outstanding  indebtedness to U.S. Trust Florida to an amount no greater than one
million dollars  ($1,000,000).  The Company's  indebtedness to its  stockholders
shall have been eliminated.

        (g) Private Placement  Exemption.  The issuance of shares of Meadowbrook
Common pursuant to the Merger will be exempt from the registration  requirements
of  Section  5 of  the  Securities  Act  pursuant  to an  appropriate  exemption
available under Regulation D under the Securities Act.



                                      -29-



<PAGE>



        (h) Registration  Rights Agreement.  Meadowbrook and the Securityholders
shall have entered into the Registration  Rights Agreement  substantially in the
form attached hereto as Exhibit D.

        (i) Amendment to Meadowbrook Bylaws.  Meadowbrook shall have amended its
Bylaws to  provide  that  Meadowbrook  shall not take any action  relating  to a
Special  Transaction  (as defined  below) unless such action is approved by four
(4) or more  directors  of  Meadowbrook.  Meadowbrook  agrees  that  such  bylaw
provision  shall  not  be  amended  or be  nullified  during  the  term  of  the
Meadowbrook Voting Agreement.  The term "Special Transaction" shall mean any of:
(i) any merger,  consolidation or other business combination by Meadowbrook with
one or more  persons in which  Meadowbrook  is not the  continuing  or surviving
corporation of such merger,  consolidation or other business  combination;  (ii)
the  dissolution  or  liquidation  of  Meadowbrook;  and (iii) any sale,  lease,
exchange, mortgage, pledge or transfer of all or substantially all of the assets
of Meadowbrook.

        (j) Material  Adverse Change.  Since the date of this  Agreement,  there
shall  not  have  been  any  material  adverse  change  on  Meadowbrook  and its
subsidiaries, taken as a whole, or any material adverse effect on the ability of
Meadowbrook to consummate the transactions  contemplated hereby. For purposes of
this  condition,  a reduction in the trading  price of  Meadowbrook  Common,  as
reported by the Nasdaq Stock Market,  whether occurring at any time or from time
to time, shall not, in and of itself, constitute a material adverse effect.

        8.3  Additional   Conditions  to  the  Obligations  of  Meadowbrook  and
Interset.  The  obligations of Meadowbrook and Interset to consummate the Merger
and the  transactions  contemplated  by this  Agreement  shall be subject to the
satisfaction at or prior to the Closing of each of the following conditions, any
of which may be waived, in writing, exclusively by Meadowbrook:

        (a) Representations  and Warranties.  The representations and warranties
of the Company contained in this Agreement shall be true and correct on the date
hereof  and on and as of the  Closing  Date,  as  though  made  on and as of the
Closing Date (except for  representations  and warranties made as of a specified
date, which need be true and correct only as of the specified date),  except for
changes  contemplated by this Agreement and except for such  inaccuracies  that,
considered  collectively,  have not had and would not  reasonably be expected to
have a Material  Adverse  Effect on the Company (it being  understood  that, for
purposes of determining the accuracy of such representations and warranties, all
"Material Adverse Effect" and other materiality qualifications contained in such
representations and warranties shall be disregarded).

        (b)  Agreements  and  Covenants.  The Company  shall have  performed  or
complied in all material respects with all agreements and covenants  required by
this  Agreement  to be  performed  or  complied  with by it on or  prior  to the
Effective Time.

        (c) Officer's Certificate.  The Company shall have furnished Meadowbrook
with a  certificate  dated the Closing  Date signed on behalf of it by its Chief
Executive  Officer or President to the effect that the  conditions  set forth in
Sections 7.7(a) and (b) have been satisfied.

        (d) Meadowbrook  Information Statement. A period of twenty (20) calendar
days  shall have  elapsed  after the date on which the  Meadowbrook  Information
Statement was sent to stockholders


                                      -30-



<PAGE>



of Meadowbrook  pursuant to Regulation 14C under the Exchange Act or Meadowbrook
shall have held a stockholders  meeting for the purposes of approving the Merger
and this Agreement.

        (e) Material  Adverse Change.  Since the date of this  Agreement,  there
shall  not  have  been  any  material  adverse  change  on the  Company  and its
Subsidiary,  taken as a whole, or any material  adverse effect on the ability of
the Company to consummate the transactions contemplated hereby.

        (f) Third Party  Consents.  Meadowbrook  shall have been  furnished with
evidence  satisfactory  to it  that  the  Company  has  obtained  the  consents,
approvals,  assignments and waivers set forth in the Disclosure Schedule, except
for such consents, approvals,  assignments and waivers that would not reasonably
be expected to have a Material Adverse Effect.

        (g) Resignations.  Meadowbrook  shall have received the resignations of
the directors and officers of the Company, to be effective  immediately upon the
Closing.

        (h) Restructuring. The Securityholders,  on behalf of the Company, shall
have caused to be paid such amounts as may be necessary to reduce the  Company's
indebtedness  to U.S.  Trust  Florida to an amount no greater  than one  million
dollars ($1,000,000).  The Company's indebtedness to its stockholders shall have
been  repaid  in  full,  together  with  interest  thereon  (including,  without
limitation, any prepayment premium). Meadowbrook shall have received evidence in
form, scope and substance satisfactory to Meadowbrook that the matters set forth
in this Section  have been  satisfied  (including  promissory  notes  evidencing
indebtedness to the Company's stockholders marked "canceled").

        (i) Private Placement Exemption. Meadowbrook shall be satisfied that the
issuance of shares of Meadowbrook  Common  pursuant to the Merger will be exempt
from the  registration  requirements of Section 5 of the Securities Act pursuant
to an appropriate  exemption  available under  Regulation D under the Securities
Act.

        (j) Fairness  Opinion.  Within  thirty  (30)  days of the  date of this
Agreement,  the Board of Directors of Meadowbrook shall have received an opinion
from  Alliant  Partners,  in a form  reasonably  satisfactory  to such  Board of
Directors,  to the effect that the Merger and the  transactions  contemplated by
this Agreement are fair to Meadowbrook from a financial point of view.


                                   ARTICLE IX

                                 INDEMNIFICATION

        9.1 Survival of  Representations  and  Warranties.  All of the Company's
representations and warranties in this Agreement,  the Disclosure Schedule,  the
supplements to the Disclosure  Schedule,  the certificate  delivered pursuant to
Section , and any other  certificate  or instrument  delivered  pursuant to this
Agreement  shall  survive the Merger and  continue  until 5:00 p.m.,  California
time,  on the earlier of the date which is one year after the Closing  Date (the
"Expiration  Date") or the applicable  statute of  limitations  and shall not be
affected by any  investigation  conducted for or on behalf of  Meadowbrook  with
respect  thereto or any  knowledge  acquired  by  Meadowbrook  or its  officers,
directors, employees, stockholders or agents as to the accuracy or inaccuracy of
any such  representation  or warranty.  The waiver of any condition based on the
accuracy of any


                                      -31-



<PAGE>



representation or warranty,  or the performance or compliance of any covenant or
obligation,  will not  affect  the  right to  indemnification  set forth in this
Article IX.

        9.2    Indemnification.

        (a)  Indemnification.  Subject to the limitations  set forth herein,  by
approval and adoption of this Agreement,  each of the Securityholders  agrees to
indemnify  Meadowbrook for such  Securityholder's pro rata portion (based on the
number of shares of Company Stock held by the  Securityholder  immediately prior
to the  Effective  Time  relative to the total number of  outstanding  shares of
Company  Stock  immediately  prior to the  Effective  Time) of  claims,  losses,
liabilities,  damages,  deficiencies,  costs and expenses,  including reasonable
attorneys'  fees  and  expenses,  and  expenses  of  investigation  and  defense
(calculated  after  deduction for insurance  proceeds  recovered or recoverable)
incurred by Meadowbrook or the Surviving Corporation directly or indirectly as a
result of any  inaccuracy  or  breach of a  representation  or  warranty  of the
Company  contained  herein  or in any  instrument  delivered  pursuant  to  this
Agreement  or any failure by the Company to perform or comply with any  covenant
contained herein (hereinafter  individually a "Loss" and collectively "Losses").
Meadowbrook   may  not  receive  any  payment  for   indemnification   from  the
Securityholders unless and until Officer's Certificates (as defined in paragraph
(c) below) identifying  Losses, the aggregate  cumulative amount of which exceed
seventy  thousand  dollars  ($70,000) have been delivered to the  Securityholder
Agent as provided in paragraph (c); in such case,  Meadowbrook  may recover from
the  Securityholders  the amount of the  cumulative  Losses on a pro rata basis;
provided, however, that the Securityholders shall have no obligation to make any
payment to Meadowbrook  with respect to any  representation  or warranty made in
good faith without actual knowledge of falsity.  Any payment for indemnification
from any Securityholder  shall be paid by the forfeiture and return of shares of
Meadowbrook  Common  received as such  Securityholder's  pro rata portion of the
Merger  Consideration.  In no event shall the maximum aggregate liability of any
Securityholder with respect to all claims of indemnification  under this Article
IX exceed  that  number of shares of  Meadowbrook  Common  equal to  twenty-five
percent  (25%)  of  such   Securityholder's  pro  rata  portion  of  the  Merger
Consideration  (valued at the average of the daily market prices of one share of
Meadowbrook  Common for thirty (30) business  days prior to the  Effective  Time
(the "Trading Price").  The daily market price of a share of Meadowbrook  Common
on any business day will be (a) the last sale price on such day on the principal
stock exchange on which shares of Meadowbrook Common are then listed or admitted
to  trading  or (b) if no sales  take  place on such  date,  the  average of the
reported bid and asked prices on such day as officially  noted on that exchange.
The Trading Price will be  appropriately  adjusted to reflect the effects of any
stock  dividend,   stock  split,   reclassification  or  combination   affecting
Meadowbrook  Common as a class,  the record  date or  ex-dividend  date of which
occurs during the period in which the Trading Price is to be determined.

        (b)    Securityholder Agent of the Securityholders; Power of Attorney.

        (i)  Each   Securityholder   appoints  Philip  Chapman,   as  agent  and
attorney-in-fact (the "Securityholder  Agent") for such Securityholder,  to give
and receive notices and  communications,  to authorize in satisfaction of claims
by Meadowbrook,  to object to such deliveries, to agree to negotiate, enter into
settlements and compromises of, and demand arbitration and comply with orders of
courts and awards of  arbitrators  with respect to such claims,  and to take all
actions necessary or appropriate in the judgment of the Securityholder Agent for
the  accomplishment  of  the  foregoing.  Such  agency  may  be  changed  by the
Securityholders from time to time upon not less


                                      -32-



<PAGE>



than thirty (30) days' prior written  notice to  Meadowbrook;  provided that the
Securityholder  Agent may not be removed  unless  two-thirds  in interest of the
Securityholders  agree to such  removal and to the  identity of the  substituted
agent.  Any  vacancy in the  position of  Securityholder  Agent may be filled by
approval  of a majority in  interest  of the  Securityholders.  No bond shall be
required of the  Securityholder  Agent, and the  Securityholder  Agent shall not
receive compensation for his services.  Notices or communications to or from the
Securityholder   Agent  shall   constitute   notice  to  or  from  each  of  the
Securityholders.

        (ii) The  Securityholder  Agent  shall not be liable for any act done or
omitted hereunder as Securityholder  Agent while acting in good faith and in the
exercise of reasonable judgment.  The Securityholders  shall severally indemnify
the Securityholder  Agent and hold the Securityholder Agent harmless against any
loss,  liability or expense incurred without negligence or bad faith on the part
of the  Securityholder  Agent  and  arising  out of or in  connection  with  the
acceptance or  administration  of the  Securityholder  Agent's duties hereunder,
including the reasonable fees and expenses of any legal counsel  retained by the
Securityholder Agent.

        (c)    Claims.

        (i) Upon  receipt by the  Securityholder  Agent at any time on or before
5:00 p.m.  California time on the Expiration Date of a certificate signed by any
officer  of  Meadowbrook   (an  "Officer's   Certificate"):   (A)  stating  that
Meadowbrook has in good faith paid or properly accrued or reasonably anticipates
that it will have to pay or accrue  Losses,  and (B)  specifying  in  reasonable
detail the individual items of Losses included in the amount so stated, the date
each such item was paid or properly  accrued,  or the basis for such anticipated
liability,  and the  nature  of the  misrepresentation,  breach of  warranty  or
covenant  to which such item is related  and to the  extent  known a  reasonable
summary of the facts  underlying the claim, and if no objection is received from
the Securityholder  Agent in accordance with Section 9.2(d), each Securityholder
shall pay to the Securityholder's Agent an amount equal to such Securityholder's
pro  rata  portion  of the  Losses  (as  limited  by  Section  9.2(a))  and  the
Securityholder  Agent shall deliver to Meadowbrook,  as promptly as practicable,
an amount equal to such Losses.

        (d)    Resolution of Conflicts; Arbitration.

        (i) If within a period of thirty (30) days following the delivery of the
Officer's  Certificate,  the Securityholder Agent shall object in writing to any
claim or claims made in any Officer's Certificate,  the Securityholder Agent and
Meadowbrook  shall  attempt  in good  faith to  agree  upon  the  rights  of the
respective  parties with respect to each of such claims.  If the  Securityholder
Agent and Meadowbrook should so agree, a memorandum setting forth such agreement
shall be prepared and signed by both parties.

        (ii) If no such  agreement can be reached after good faith  negotiation,
either  Meadowbrook or the  Securityholder  Agent may demand  arbitration of the
matter unless the amount of the damage or loss is at issue in pending litigation
with a third party, in which event arbitration shall not be commenced until such
amount is ascertained or both parties agree to  arbitration;  and in either such
event the matter shall be settled by arbitration conducted by three arbitrators.
Meadowbrook and the Securityholder  Agent shall each select one arbitrator,  and
the two arbitrators so selected shall select a third  arbitrator,  each of which
arbitrators  shall be  independent  and have at least  ten (10)  years  relevant
experience.  The  arbitrators  shall set a limited  time  period  and  establish
procedures


                                      -33-



<PAGE>



designed to reduce the cost and time for discovery while allowing the parties an
opportunity,  adequate  in the sole  judgment  of the  arbitrators,  to discover
relevant  information  from the opposing parties about the subject matter of the
dispute.  The  arbitrators  shall rule upon motions to compel or limit discovery
and shall have the authority to impose sanctions,  including attorneys' fees and
costs,  to the  extent  as a  court  of  competent  law or  equity,  should  the
arbitrators   determine   that   discovery   was  sought   without   substantial
justification  or that discovery was refused or objected to without  substantial
justification.  The  decision of a majority of the three  arbitrators  as to the
validity and amount of any claim in such Officer's  Certificate shall be binding
and  conclusive  upon the  parties to this  Agreement.  Such  decision  shall be
written and shall be supported by written findings of fact and conclusions which
shall set forth the award, judgment, decree or order awarded by the arbitrators.

        (iii) Judgment upon any award rendered by the arbitrators may be entered
in any court  having  jurisdiction.  Any such  arbitration  shall be held in San
Francisco,  California,  under the rules then in effect of Judicial  Arbitration
and Mediation Services, Inc.

        (e) Actions of the  Securityholder  Agent. A decision,  act,  consent or
instruction of the  Securityholder  Agent shall constitute a decision of all the
Securityholders  and shall be final,  binding  and  conclusive  upon each of the
Securityholders,  and Meadowbrook may rely upon any such decision,  act, consent
or instruction of the Securityholder  Agent as being the decision,  act, consent
or instruction of each  Securityholder.  Meadowbrook is hereby relieved from any
liability  to any  person  for any acts  done by them in  accordance  with  such
decision, act, consent or instruction of the Securityholder Agent.

        (f)  Third-Party  Claims.  In the event  Meadowbrook  becomes aware of a
third-party claim which Meadowbrook  believes may result in a demand against the
Securityholders,  Meadowbrook  shall  notify  the  Securityholder  Agent of such
claim, and the Securityholder  Agent, as representative for the Securityholders,
shall be  entitled,  at their  expense,  to  participate  in any defense of such
claim.  Meadowbrook  shall have the right in its sole  discretion  to settle any
such   claim;   provided,   however,   that  except  with  the  consent  of  the
Securityholder Agent, no settlement of any such claim with third-party claimants
shall  alone  be   determinative   of  the  amount  of  any  claim  against  the
Securityholders.  In the event that the  Securityholder  Agent has  consented in
writing to any such settlement and acknowledged that the claim by Meadowbrook is
a valid claim against the  Securityholders,  the Securityholder Agent shall have
no power or authority  to object  under any  provision of this Article IX to the
amount of any claim by Meadowbrook against the  Securityholders  with respect to
such settlement.

        9.3  Exclusivity  of  Remedy.  The  indemnification  remedies  and other
remedies  provided  in  this  Article  IX  shall  be  deemed  to  be  exclusive.
Accordingly,  the  exercise by  Meadowbrook  of its rights under this Article IX
shall be deemed to be an election of remedies and shall be deemed to  prejudice,
or to  constitute or operate as a waiver of, any other right or remedy that such
person may be entitled  to exercise  (whether  under this  Agreement,  under any
other agreement or instrument,  under any statute,  rule or other  regulation or
ordinance, at common law, in equity or otherwise).




                                      -34-



<PAGE>



                                    ARTICLE X

                     TERMINATION, AMENDMENT, WAIVER, CLOSING

        10.1  Termination.  Except as  provided  in  Section  10.2  below,  this
Agreement  may be terminated  and the Merger  abandoned at any time prior to the
Effective Time:

        (a) By mutual consent of the Company and Meadowbrook;

        (b) By  Meadowbrook  or the Company if: (i) the  Effective  Time has not
occurred by July 31, 1998  (provided  that the right to terminate this Agreement
under this clause (i) shall not be available to any party whose willful  failure
to fulfill any  obligation  hereunder has been the cause of, or resulted in, the
failure of the Effective Time to occur on or before such date); (ii) there shall
be a final  non-appealable  order,  decree  or  ruling  of a court of  competent
jurisdiction in effect preventing  consummation of the Merger; (iii) there shall
be any statute, rule, regulation or non-appealable order enacted, promulgated or
issued or deemed applicable to the Merger by any governmental  entity that would
make  consummation of the Merger  illegal;  or (iv) the approval and adoption of
this Agreement by the Company's stockholders shall not have been obtained;

        (c) By Meadowbrook or the Company if there shall be any action taken, or
any statute, rule, regulation or order enacted,  promulgated or issued or deemed
applicable to the Merger, by any governmental  entity, which would: (i) prohibit
Meadowbrook's  or the  Company's  ownership  or  operation of any portion of the
business of the Company or (ii) compel  Meadowbrook or the Company to dispose of
or hold  separate,  as a result of the Merger,  any  portion of the  business or
assets of the Company or  Meadowbrook;  in either case,  the  unavailability  of
which assets or business would be reasonably expected to have a Material Adverse
Effect on Meadowbrook or would reasonably be expected to have a material adverse
effect on  Meadowbrook's  ability  to realize  the  benefits  expected  from the
Merger.

        (d)  By   Meadowbrook   if  it  is  not  in   material   breach  of  its
representations,  warranties or  obligations  under this Agreement and there has
been a breach of any representation,  warranty,  covenant or agreement contained
in  this  Agreement  on the  part of the  Company  or if any  representation  or
warranty of the Company shall have become  untrue,  in either case such that the
conditions set forth in Section 8.3 would not be satisfied;  provided,  however,
if such  breach or breaches  are  capable of being cured prior to the  Effective
Time,  such  breaches  shall  not have been  cured  within  thirty  (30) days of
delivery  to the Company of written  notice of such  breach or breaches  (but no
such cure  period  shall be  required  if such  breach by its  nature  cannot be
cured);

        (e)  By  the   Company  if  it  is  not  in   material   breach  of  its
representations,  warranties or  obligations  under this Agreement and there has
been a breach of any representation,  warranty,  covenant or agreement contained
in  this   Agreement  on  the  part  of   Meadowbrook  or  Interset  or  if  any
representation  or warranty of Meadowbrook or Interset shall have become untrue,
in either  case such that the  conditions  set forth in Section 8.2 would not be
satisfied;  provided,  however,  if such breach or breaches are capable of being
cured  prior to the  Effective  Time,  such  breaches  shall not have been cured
within  thirty (30) days of delivery to  Meadowbrook  of written  notice of such
breach or breaches  (but no such cure period shall be required if such breach by
its nature cannot be cured);



                                      -35-



<PAGE>



        Where  action is taken to  terminate  this  Agreement  pursuant  to this
Section  10.1,  it shall be  sufficient  for such action to be authorized by the
Board of Directors (as applicable) of the party taking such action.

        10.2  Effect  of  Termination.  In the  event  of  termination  of  this
Agreement as provided in Section 10.1,  this Agreement  shall  forthwith  become
void and,  except as set forth in Section  10.3,  there shall be no liability or
obligation  on the  part of  Meadowbrook,  Interset  or the  Company,  or  their
respective subsidiaries, officers, directors or stockholders, provided that, the
provisions of Sections 7.4 and 7.5 and Article X of this Agreement  shall remain
in full force and effect and survive any termination of this Agreement.

        10.3   Termination Fee.

        (a) The Company  shall pay to  Meadowbrook,  a  termination  fee of five
hundred thousand dollars  ($500,000) in cash by wire transfer or cashier's check
in the event that the Closing  does not occur,  this  Agreement  is  terminated,
Meadowbrook is not in material breach of its  obligations  under this Agreement,
and the  Company has  willfully  and  materially  breached  any  representation,
warranty, covenant or agreement contained in this Agreement.

        (b)  Meadowbrook  shall pay to the Company,  a  termination  fee of five
hundred thousand dollars  ($500,000) in cash by wire transfer or cashier's check
in the event that the Closing does not occur, this Agreement is terminated,  the
Company is not in material breach of its obligations  under this Agreement,  and
Meadowbrook has willfully and materially breached any representation,  warranty,
covenant or agreement contained in this Agreement.

        (c) Any  termination  payment  payable by the Company under this Section
10.3 shall be made  within ten (10)  calendar  days  after  termination  of this
Agreement.

        (d) The  payments  called for by this Section 10.3 shall be deemed to be
liquidated  damages and shall be in addition to any rights or remedies at law or
equity arising out of a breach of the obligations set forth in this Agreement.

        10.4  Amendment  or  Supplement.   This  Agreement  may  be  amended  or
supplemented  at any time  before or after  approval  of this  Agreement  by the
stockholders  of the  Company  to the  extent  permitted  under of the CGCL.  No
amendment or supplement  shall be effective  unless in writing and signed by the
party or parties sought to be bound thereby.

        Subject to the preceding  paragraph,  this Agreement may be amended in a
writing  executed  by the Chief  Executive  Officer of the Company and the Chief
Executive  Officer of Meadowbrook in order to modify the structure of the Merger
to  substitute  for  Interset  another  directly  or  indirectly   wholly  owned
subsidiary of Meadowbrook, pursuant to which such Subsidiary shall then become a
party to this  Agreement and all  references in this agreement to Interset shall
thereafter be deemed to refer to such substituted subsidiary of Meadowbrook.

        10.5 Extension of Time, Waiver. At any time prior to the Effective Time,
Meadowbrook and Interset,  on the one hand, and Company, on the other hand, may,
to the extent legally allowed:



                                      -36-



<PAGE>



        (a) Extend the time for the  performance  of any of the  obligations  or
        other acts of the other party hereto,

        (b) Waive any inaccuracies in the representations and warranties made to
        such  party  contained  herein  or in any  document  delivered  pursuant
        hereto, and

        (c) Waive  compliance  with any of the  agreements or conditions for the
        benefit of such party  contained  herein except the conditions set forth
        in Sections  10.3(a) and 10.3(b)  hereof;  provided,  that no failure or
        delay by any  party  hereto in  exercising  any  right  hereunder  shall
        operate as a waiver  thereof  nor shall any  single or partial  exercise
        thereof  preclude any other or further  exercise thereof or the exercise
        of any other right hereunder.

Any  agreement on the part of any party  hereto to any such  extension or waiver
shall be valid if set forth in an instrument in writing signed on behalf of such
party.


                                   ARTICLE XI

                                     GENERAL

        11.1 Notices. Any notice,  request,  instruction or other document to be
given  hereunder  by any party to the other  shall be in writing  and  delivered
personally or sent by certified mail, postage prepaid, by telecopy (with receipt
confirmed and promptly confirmed by personal delivery, U.S. first class mail, or
courier), or by courier service, as follows:

        (a)    If to Meadowbrook or Interset to:

               Meadowbrook Rehabilitation Group, Inc.
               2000 Powell Street, Suite 1203
               Emeryville, CA  94608
               Attn:  Chief Executive Officer
               Fax:  (510) 420-7008

        with a copy to:

               Pillsbury Madison & Sutro LLP
               235 Montgomery Street
               San Francisco, CA 94104
               Attn:  Blair W. White, Esq.
               Fax:  (415) 983-1200

        (b) If to the Company to:

               Cambio Networks, Inc.
               154 SE 30th Place, Suite 200
               Bellevue, WA 98007
               Attn:  President and Chief Executive Officer
               Fax:  (425) 643-2005


                                      -37-



<PAGE>




        with a copy to:

               Cooley Godward LLP
               Five Palo Alto Square
               3000 El Camino Real
               Palo Alto, CA 94306-2155
               Attn:  Michael Sullivan, Esq.
               Fax:  (650) 857-0663

        (c) If to a Securityholder to:

               The last known address on the
               Company's stock ledger

        with a copy to:

               Cooley Godward LLP
               Five Palo Alto Square
               3000 El Camino Real
               Palo Alto, CA 94306-2155
               Attn:  Michael Sullivan, Esq.
               Fax:  (650) 857-0663

        (d) If to the Securityholder Agent:

               Philip Chapman
               c/o Venad Administrative Services, Inc.
               100 First Stamford Place
               Stamford, CT 06902
               Fax:  (203) 359-0880

or to such other persons as may be  designated  in writing by the parties,  by a
notice given as aforesaid.

        11.2  Headings.  The headings of the several  sections of this Agreement
are inserted for  convenience  of reference  only and are not intended to affect
the meaning or interpretation of this Agreement.

        11.3 Counterparts.  This Agreement may be executed in counterparts,  and
when so executed each  counterpart  shall be deemed to be an original,  and said
counterparts together shall constitute one and the same instrument.

        11.4 Entire  Agreement;  Assignment.  This Agreement,  the Schedules and
Exhibits  hereto  (including  the  Disclosure  Schedule),  and the documents and
instruments and other agreements among the parties hereto referenced herein: (a)
constitute  the entire  agreement  among the parties with respect to the subject
matter  hereof and  supersede  all prior  agreements  and  understandings,  both
written and oral,  among the parties with respect to the subject  matter hereof;
(b) are not  intended  to confer  upon any other  person any rights or  remedies
hereunder (except as provided in


                                      -38-



<PAGE>



Section below); and (c), except as contemplated by Section shall not be assigned
by operation of law or otherwise  except as mutually  agreed in writing  between
the parties

        11.5 Severability.  In the event that any provision of this Agreement or
the  application  thereof,  becomes  or is  declared  by a  court  of  competent
jurisdiction  to be  illegal,  void  or  unenforceable,  the  remainder  of this
Agreement  will  continue in full force and effect and the  application  of such
provision to other persons or circumstances will be interpreted so as reasonably
to effect the intent of the parties hereto. The parties further agree to replace
such  void or  unenforceable  provision  of  this  Agreement  with a  valid  and
enforceable  provision that will achieve, to the extent possible,  the economic,
business and other purposes of such void or unenforceable provision.

        11.6 Other Remedies.  Except as otherwise  provided herein,  any and all
remedies herein expressly  conferred upon a party will be deemed cumulative with
and not exclusive of any other remedy conferred hereby, or by law or equity upon
such party,  and the exercise by a party of any one remedy will not preclude the
exercise of any other remedy.

        11.7 Governing Law. This Agreement shall be governed by and construed in
accordance  with the laws of the State of Delaware,  regardless of the laws that
might otherwise govern under applicable principles of conflicts of laws thereof,
except to the extent that the laws of the State of  California  are  mandatorily
applicable to the Merger.  Each of the parties hereto agrees that process may be
served them in any manner  authorized  by the laws of the State of Delaware  for
such persons and waives and covenants not to assert or plead any objection which
they might otherwise have to such jurisdiction and such process.

        11.8 Absence of  Third-Party  Beneficiary  Rights.  No provision of this
Agreement is intended,  or will be interpreted,  to provide to or create for any
third-party  beneficiary  rights or any other  rights of any kind in any client,
customer, affiliate,  shareholder,  employee, partner or any party hereto or any
other  person or entity,  and all  provisions  hereof  will be  personal  solely
between the parties to this  Agreement,  except that the  provisions  of Section
7.16 shall be for the benefit of, and enforceable  by, the  indemnified  persons
referred to therein.

                            [Signature page follows]




                                      -39-



<PAGE>



        IN WITNESS  WHEREOF,  the  parties  have  caused  this  Agreement  to be
executed, all as of the date first above written.

MEADOWBROOK REHABILITATION GROUP,
INC.



By /s/  Harvey Wm. Glasser

Title   President


INTERSET, INC.



By /s/  Harvey Wm. Glasser

Title   President


CAMBIO NETWORKS, INC.



By /s/  Gari Grimm

Title   President & COO


SECURITYHOLDERS:

EURO-AMERICA-II, L.P.



By /s/  Frederick R. Adler

Title   General Partner




                                      -40-



<PAGE>


2001 PARTNERS, L.P.



By /s/  Elizabeth A. Wertheimer

Title   General Partner




   /s/  Frederick Adler

        Frederick Adler




   /s/  Joseph K. Pagano

        Joseph K. Pagano




   /s/  Philip Chapman

        Philip Chapman



                                      -41-





                                  Exhibit 2.2


<PAGE>

                          SECURED BRIDGE FINANCING NOTE


                                                            Bellevue, Washington
                                                                   April 3, 1998


         1. FOR VALUE RECEIVED,  CAMBIO NETWORKS, INC., a California corporation
(the  "Borrower"),  promises to pay to the order of  MEADOWBROOK  REHABILITATION
GROUP,  INC., a Delaware  corporation  (the  "Holder"),  the  principal sum (the
"Principal Sum") of Five Hundred Thousand Dollars  ($500,000),  or, if less, the
aggregate  principal  amount  of all  outstanding  borrowings  made by Holder to
Borrower  for current  operating  expenses  of  Borrower  pursuant to Schedule 1
attached hereto and made a part hereof.  Borrower  promises to pay interest from
the date hereof on the advanced and unpaid  amount of such  Principal Sum and on
any accrued,  unpaid and overdue  installments of interest,  on the dates and at
the rate of interest hereinafter set forth.

         2. Term.  Unless  accelerated  pursuant to the terms of this Note,  the
unpaid portion of the Principal Sum and all accrued and unpaid interest  thereon
shall be due and payable in full on the date (the  "Maturity  Date") that is the
earlier to occur of (i) the date on which the Agreement and Plan of Merger among
Holder,  Borrower and Interset, Inc. dated as of April 3, 1998 closes; (ii) July
31, 1998;  (iii) the date on which Borrower  closes any equity or debt financing
in excess of $50,000  subsequent to the date hereof;  (iv) the date on which all
or any  significant  portion of the assets or business  of Borrower  are sold or
otherwise  transferred;  or (v) the date on which  there  occurs any  "change in
control"  of  Borrower  (defined  as a  sale  or  other  transfer,  directly  or
indirectly,  of 30% or more of the  beneficial  voting or  economic  interest of
Borrower).

         3.  Interest.  Interest,  which  shall be  computed on the basis of the
actual number of days elapsed,  shall accrue  monthly on the advanced and unpaid
amount of the Principal  Sum and on any then accrued and unpaid  interest at the
rate of eight percent  (8.0%) per annum until the Maturity  Date,  increasing by
and additional  fifty (50) basis points at the end of each month  thereafter for
so long as this Note is outstanding.

         4. Place of Payment and Notice.  Payments on this Note,  as well as any
notices to Holder,  are to be mailed or given to Holder at 2000  Powell  Street,
Suite 1203,  Emeryville,  California 94608, or to such other place as Holder may
from time to time direct by written  notice to Borrower.  The address for notice
to Borrower shall be 154 SE 30th Place, Suite 200,  Bellevue,  Washington 98007,
or to such  other  place as  Borrower  may from time to time  direct by  written
notice to Holder.

         5. Representations of Borrower. Borrower hereby represents and warrants
to Holder that (a) Borrower is a corporation duly organized and validly existing
in good standing under the laws of the State of California; (b) Borrower has all
necessary  corporate  power and  authority  to execute,  deliver and perform its
obligations under this Note and consummate the transactions contemplated hereby;
and  (c)  the  execution,   delivery  and  performance  of  this  Note  and  the
consummation of the transactions  contemplated  hereby have been duly authorized
by all necessary  corporate action on the part of Borrower and do not violate or
conflict with, or, with or without the giving of notice,  the passage of time or
both, constitute a default under,  Borrower's charter documents,  any law, rule,
regulation,  order,  writ,  injunction  or decree of any  court,  administrative
agency or any other governmental  authority applicable to Borrower or any of its
properties or any  agreement,  instrument  or commitment to which  Borrower is a
party or by which Borrower or any of its property is bound.

         6. Lawful Tender.  All amounts payable  hereunder shall be payable only
in lawful money of the United State of America.  Each payment received by Holder
under  this Note  shall be applied  first to the  payment of accrued  but unpaid
interest due hereunder and second to the Principal  Sum. If any  installment  or
payment on this Note shall be due on  Saturday,  Sunday or a day which is a bank
holiday in the State of  California,  such payment  shall be extended  until the
following business day with accrued interest.

         7. Prepayment. Borrower may make prepayments to Holder of the Principal
Sum at any time, in whole or in part, without premium or penalty.

         8.       Default.

         (a) An  "Event  of  Default"  shall  exist  if any  one or  more of the
following  events  (collectively,  "Events  of  Default")  shall  occur  and  be
continuing:

                  (i)   Borrower   shall  fail  to  pay  when  due  (whether  by
acceleration or otherwise) any payment of principal or of interest on this Note,
and such failure continues for a period of five (5) days;

                  (ii) Any  representation  or warranty  made by Borrower  under
this Note shall prove to be untrue or inaccurate  in any material  respect as of
the date on which such representation or warranty is made;

                  (iii)  Default  shall occur in the  performance  of any of the
covenants  or  agreements  of Borrower  contained  herein  (other  than  payment
defaults),  which is not  remedied  within  thirty  (30) days after  delivery of
written notice to Borrower from Holder;

                  (iv)  Default  shall  occur  in the  payment  of any  material
indebtedness  of Borrower (or default  shall occur in respect of any note,  loan
agreement or credit agreement relating to such indebtedness or such indebtedness
shall  become due before its stated  maturity by  acceleration  thereof or shall
become due by its terms and shall not be promptly paid or extended) or a default
shall occur under any material  agreement of  Borrower,  and such default  shall
continue for more than the period of grace, if any, specified therein;

                  (v) Borrower or any subsidiary  shall (A) apply for or consent
to the appointment of a receiver, trustee, custodian or liquidator or itself, of
all or  substantially  all of its  assets,  (B)  file a  voluntary  petition  in
bankruptcy, admit in writing that such person is unable to pay its debts as they
become  due or  generally  not pay such  debts as they  become  due,  (C) make a
general  assignment for the benefit of creditors,  (D) file a petition or answer
seeking reorganization of any arrangement with creditors or to take advantage of
any bankruptcy,  reorganization or insolvency proceeding,  or (E) take corporate
action for the purpose of affecting any of the foregoing;

                  (vi) An  involuntary  petition  or  complaint  shall  be filed
against Borrower or any subsidiary  seeking bankruptcy or reorganization of such
person or the  appointment  of a receiver,  custodian,  trustee or liquidator of
such person,  or all or substantially  all of such person's assets, or an order,
order for relief,  judgment or decree shall be entered by any court of competent
jurisdiction  or other  competent  authority  approving a petition or  complaint
seeking reorganization of Borrower or any subsidiary,  or appointing a receiver,
custodian,  trustee or liquidator of such person, or of all or substantially all
of such person's assets,  and, in each case, such petition,  order,  judgment or
decree  shall not have  been  dismissed  within  sixty  (60) days of the  filing
thereof; or

                  (vii) Any final judgment(s) for the payment of money in excess
of the sum of $50,000 in the aggregate  shall be rendered  against  Borrower and
such judgment or judgments  shall not be satisfied or  discharged  within thirty
(30) days of the date on which any such judgment is issued.

         (b) If an Event of Default shall have occurred and be continuing,  then
Holder may declare the unpaid  Principal  Sum of, and all interest  then accrued
but unpaid on, this Note and any other liabilities hereunder to be forthwith due
and payable,  whereupon the same shall forthwith  become due and payable without
presentment,  demand,  protest,  notice of default, notice of acceleration or of
intention  to  accelerate  or other  notice of any kind,  all of which  Borrower
hereby expressly waives.

         (c) Each right,  power or remedy of Holder upon the  occurrence  of any
Event of Default as provided  for in this Note or now or  hereafter  existing at
law or in equity or by statute shall be cumulative  and  concurrent and shall be
in addition to every other right,  power or remedy  provided for in this Note or
now or hereafter existing at law or in equity or by statute, and the exercise or
beginning of the exercise by Holder of any one or more of such rights, powers or
remedies shall not preclude the  simultaneous or later exercise by Holder of any
or all such other rights, powers or remedies.

         (d) Upon the occurrence of an Event of Default,  Borrower agrees to pay
all  costs  and  expenses  (including  Holder's  attorneys'  fees and  expenses)
reasonably  incurred by Holder in connection  with the collection of amounts due
hereunder or the preservation and enforcement of Holder's rights  hereunder,  or
relating to any reorganization or workout in connection herewith.

         9. CONSENT TO  JURISDICTION.  BORROWER  HEREBY AGREES AND CONSENTS THAT
ANY ACTION,  SUIT OR  PROCEEDING  ARISING OUT OF THIS NOTE MAY BE BROUGHT IN ANY
APPROPRIATE  FEDERAL OR STATE COURT IN THE STATE OF CALIFORNIA,  OR IN ANY OTHER
COURT HAVING JURISDICTION OVER THE SUBJECT MATTER, ALL AT THE SOLE AND EXCLUSIVE
ELECTION  OF  HOLDER,  AND BY THE  ISSUANCE  AND  EXECUTION  OF  THIS  NOTE  AND
ACCEPTANCE  OF  THE  LOAN  PROCEEDS   BORROWER   IRREVOCABLY   CONSENTS  TO  THE
JURISDICTION AND VENUE OF EACH SUCH COURT AND HEREBY IRREVOCABLY  WAIVES, TO THE
FULLEST  EXTENT  PERMITTED BY LAW, ANY  OBJECTION  WHICH IT MAY NOW OR HEREAFTER
HAVE TO THE LAYING OF VENUE IN ANY SUCH COURT.

         10.  Waiver.  No failure to  exercise  and no delay in  exercising  any
right, power or privilege hereunder shall operate as a waiver thereof, nor shall
any  single or  partial  exercise  of any right,  power or  privilege  hereunder
preclude any other right, power or privilege. Amendments or waivers to this Note
may be made only in a written instrument executed by Borrower and Holder.

         11.  Headings.  The  headings  in  this  Note  are for  convenience  of
reference only and do not constitute part of this Note.

         12.  Maximum  Interest.  The  provisions  of  this  Note  shall  not be
construed as requiring or  committing  Borrower to pay interest in excess of the
highest rate permitted by applicable  law. If a court of competent  jurisdiction
should  determine  that  Holder has  received  interest in excess of such lawful
rate, such excess shall be applied to the reduction of the unpaid  Principal Sum
due hereunder and not to the payment of interest.

         13. Grant and Perfection of Security  Interest.  In order to secure the
due and punctual  payment of the sums due  hereunder,  Borrower  hereby  grants,
transfers,  conveys  and  assigns  to  Holder,  and  grants to Holder a security
interest in, Borrower's  presently existing or hereafter acquired rights,  title
and  interest in all of its tangible and  intangible  property,  whether real or
personal,   including,   without  limitation,  all  Accounts,  Contract  Rights,
Inventory,  Equipment,  General  Intangibles,  Chattel Paper,  Deposit Accounts,
Goods,  Documents,  Instruments  and  Proceeds  (each as defined in the  Uniform
Commercial Code) of the foregoing  (collectively,  the  "Collateral");  provided
however,  that Holder's security interest in the Collateral shall be subordinate
to all security  interests in the  Collateral  granted by Borrower and perfected
prior to the date hereof.

         14.  Attorneys'  Fees.  Should any  litigation  or other  proceeding be
commenced by Borrower or Holder  concerning  this Note, or the rights and duties
of the parties in relation  to this Note or any matter in  connection  herewith,
the party  prevailing in such litigation or other  proceeding shall be entitled,
in addition to such other  relief as may be granted,  to recover its  reasonable
attorneys'  fees and costs incurred in connection  with such litigation or other
proceeding.

         15.  Further  Assurances.  From time to time after the date  hereof and
without further consideration, Borrower will execute and deliver, or arrange for
the execution and delivery of such other  instruments of conveyance and transfer
or other  instruments or documents and take or arrange for such other actions as
may  reasonably  be  requested  by  Holder  to  complete  more  effectively  the
transactions  contemplated  hereby,  including,  without  limitation,  as may be
necessary to implement the provisions of Section 13 above.

         16.  Governing  Law.  THIS NOTE SHALL BE GOVERNED BY AND  CONSTRUED AND
ENFORCED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF CALIFORNIA.

         IN WITNESS WHEREOF, the undersigned Borrower has caused this Note to be
duly executed on the date of issue above stated.

                                                        BORROWER:

                                                        CAMBIO NETWORKS, INC.,
                                                        a California corporation


                                                        By /s/ Gari Grimm

                                                        Its President & COO

Address:

154 SE 30th Place, Suite 200
Bellevue, Washington 98007





                                  Exhibit 99.1


<PAGE>

CONTACT:
MEADOWBROOK REHABILITATION GROUP, INC.
Harvey Wm. Glasser, M.D.             -or-                Wm. Samuel Veazey
Chairman, President & CEO                                Chief Financial Officer
(510)420-0900
                              FOR IMMEDIATE RELEASE

                  MEADOWBROOK REHABILITATION GROUP, INC. SIGNS
                          AGREEMENT AND PLAN OF MERGER

         Emeryville,  CA - April 7,  1998 -  Meadowbrook  Rehabilitation  Group,
Inc.,  (Nasdaq:  MBRK), today announced that it has signed an Agreement and Plan
of  Merger  (the  "Agreement")  for the  acquisition  of Cambio  Networks,  Inc.
("Cambio"). Under the terms of the Agreement, Cambio's current shareholders will
receive Meadowbrook's Class A common stock representing 32.5% of the outstanding
Class A and Class B common stock at the time of the closing.

         The closing of the merger is subject to several  conditions,  including
the approval of the stockholders of each of Meadowbrook and Cambio. If these and
certain other conditions are met, the transaction is anticipated to be completed
by the end of June 1998.

         Cambio is a network  management  inventory  software company  providing
services to financial,  telephony,  medical and Y2K markets in both the U.S. and
Common Market.  Cambio's COMMAND Network Inventory  Management System provides a
comprehensive solution for network inventory management,  that enables customers
to optimize the  management of a  corporation's  network  infrastructure  - both
physical and logical.

         Harvey Wm. Glasser, Chairman,  President and Chief Executive Officer of
Meadowbrook,  commented,  "This acquisition supports  Meadowbrook's  strategy to
acquire or make investments in non-medical businesses with established positions
in targeted  markets.  Cambio has been a leader in the complex network inventory
management  industry  and its  product  provides a solution  which is becoming a
necessity as networks increase in speed and complexity."

         Gari  Grimm,  President  and CEO of Cambio,  noted,  "We  welcome  this
opportunity to join forces with Meadowbrook and together,  we expect to continue
to implement Cambio's strategy of initially targeting the telecommunications and
financial  services  industries  which  we  believe  have the  highest  level of
competitive urgency."

         Statements,  either  written  or  oral,  which  express  the  Company's
expectation  for the future with respect to financial  performance  or operating
strategies can be identified as forward-looking statements. These statements are
made to  provide  the  public  with  management's  assessment  of the  Company's
business.  Caution  must be taken to  consider  these  statements  in light of a
number of factors  discussed in the Company's  filings with the  Securities  and
Exchange  Commission.  In the event  such  factors  do not  occur as  management
anticipates,  actual  results  could  differ  materially  from the  expectations
expressed in any forward-looking statements.

         Meadowbrook  Rehabilitation  Group,  Inc. owns and operates home health
agencies in Colorado and Kansas. In addition,  Meadowbrook's  long-term strategy
includes non-medical investments such as the acquisition announced today.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission